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ABSTRACT  
Microdialysis (MD) sampling is a diffusion-based separation method which has the 
ability to sample any analyte that can diffuse across the semi-permeable membrane. However 
one challenge for MD is that for soluble proteins greater than 10 kDa, the relative recovery (RR) 
using a 100 kDa MD probe is between 1-5%.
1
  There are two major barriers that lead to these 
low recovery values - nonspecific adsorption (NSA) and poor solute mass transport. To 
overcome these two barriers, the modification of PES-based MD membranes has been initiated 
by laccase.  Previous researchers have used laccase to modify PES flat sheet and hollow fiber 
membranes using 4HBA to create  a hydrophilic polymer chain network.
2
  Furthermore by 
functionalizing the MD membranes with carboxylic acid functional groups from 4HBA, one can 
easily modify the surface.
3
 This study focuses on characterization of the PES membrane surface 
before and after attachment of 4HBA polymers and heparin. First the attachment of 4HBA and 
heparin has been confirmed using XPS and ATR-FTIR.  Next protein adsorption measurements 
were performed for 4HBA modified flat sheets which showed an initial increase in BSA 
adsorption followed by a decrease in BSA adsorption after 24 hours of modification.  However, 
for positively charged lysozyme the protein adsorption increased upon modification.  RR 
experiments were performed using FITC-labeled dextrans, lysozyme, CCL2, VEGF, TNF-, 
KC/GRO and aFGF.  After modification with 4HBA for 2 hours, RR of CCL2, KC/GRO, and 
VEGF increased 2 to 3 times compared to the control relative recovery however, this increase in 
RR was not observed for aFGF and TNF-.  This difference could be due to the isoelectric 
points (pI) of these proteins indicating an electrostatic interaction between the surface and the 
protein.  For 24 hour 4HBA-heparin modified membranes CCL2 RR increased twofold for hours 
3 and 4 and for 2 hour 4HBA-heparin modified membranes aFGF RR increase threefold.   
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CHAPTER 1.  INTRODUCTION 
 
Significance 
The work in this dissertation is focused on developing membranes to improve mass 
transport through covalent addition of 4-hydroxybenzoic acid (4HBA) polymers, and heparin to 
the microdialysis membrane surface.  One significant challenge to microdialysis is that mass 
transport is low for large soluble signaling proteins (>10 kDa).  These signaling molecules help 
cells, perceive and respond to their microenvironment and are found to be involved in processes 
such as inflammation, and immunity.
4
  Another challenge for microdialysis is the nonspecific 
adsorption of protein molecules to the dialysis membrane and tubing, this decreases the effective 
pore size of the membrane and causes loss of analytes, leading to a decrease in recovery.
5
  By 
attaching hydrophilic phenolic compounds (4-hydroxybenzoic acid polymers) onto the 
membrane surface, relative recovery of CCL2, KC/GRO, and VEGF, after 2 hours of 
modification increase two to three times and relative recovery of aFGF increased at hour 4.  RR 
of TNF- did not increase for the 2 hour 4HBA modification.   The difference between these two 
groups of proteins is their isoelectric point’s which can indicate an interaction between the 
charged surface and the overall charge of the protein.  By covalent attachment of heparin to the 
membrane, relative recovery of CCL2 increased two times after hour 2 and VEGF increased for 
the 24 hour 4HBA modified MD probes and aFGF relative recovery, after a 2 hour 4HBA 
modification time, increased starting at hour 3. 
Microdialysis Sampling 
Microdialysis sampling is a diffusion-based separation method that allows analytes to 
freely diffuse across a semi-permeable dialysis membrane (Figure 1).
3
   
2 
 
 
Figure 1.  Microdialysis probe and relative recovery experimental design. 
 
Commercially available membranes range in molecular weight cut-off (MWCO) from 6 to 1,000 
kDa and are made up of a variety of membrane materials such as polyethersulfone, 
polycarbonate, and polyarylethersulphone.  Microdialysis sampling of a given analyte is 
governed by the mass transport of the molecule from an external medium, through the 
membrane, and into the perfusing fluid.
6
  Factors such as membrane physical dimensions, device 
accessible volume, perfusate flow rate, and analyte diffusion coefficients strongly influence 
relative recovery.
6
  Microdialysis sampling is an ideal technique to achieve real time monitoring 
at the site of probe implantation within living systems.
7
  The application of microdialysis is 
emerging as an approach for clinical in vivo studies in both healthy and diseased subjects to 
recover targeted molecules.
8-11
  Microdialysis probes are made with a variety of MWCO’s and 
membrane chemistry.  MWCO is defined as the molecular weight at which 80% of the analyte is 
prohibited from membrane diffusion.
12
  However, MWCO is typically determined from 
C
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equilibrium mass transport, which is not an exact representation of the non-equilibrium setting of 
microdialysis.
6
  One of the parameters commonly measured for microdialysis is relative recovery 
(RR).  This is used to estimate the concentration external to the probe.   
                 [1] 
As shown in Equation 1, RR is defined by the difference between the concentration of analyte in 
the dialysate (Coutlet) and the concentration of analyte added in the perfusion fluid (Cinlet), which 
is typically zero, divided by the difference between the concentration of the analyte in the sample 
(Csample), and Cinlet multiplied by 100.  RR is dependent on many factors such as the perfusion 
flow rate, membrane surface area, MWCO, and temperature, analyte, and matrix properties of 
the external media.
10, 13-15
  As the flow rate decreases the concentration of analyte in the dialysate 
increases leading to an increase in relative recovery.  Also as the surface area of the membrane 
increases, relative recovery increases due to the increase of contact between the solution and the 
membrane surface.  An increase in MWCO leads to increased relative recovery however with 
increasing the MWCO, ultrafiltration leading to fluid loss in the dialysate becomes an issue.  
There are several techniques used to determine RR for in vivo studies, in vitro microdialysis, no-
net flux, ultra-slow or zero flow rate method, internal standard, endogenous reference and 
retrodialysis.
16
  The most commonly used technique is an in vitro recovery experiment, where 
the probe is placed in a solution containing a known amount of the analyte.  The perfusion fluid 
is perfused through the probe and collected for quantification of the analyte.  RR can then be 
calculated using Equation 1, knowing the external concentration in which the probe is placed and 
the amount collected in the perfusion fluid.   

RR 
Cou tlet Cin let
Csamp leCin let
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Challenges to Microdialysis Sampling 
Microdialysis is a diffusion-based technique, so RR is highly dependent upon analyte 
diffusion properties.
7
  Since microdialysis is not an equilibrium process due to the continuous 
flow of the perfusion fluid, RR is generally less than 100%.
7
  One of the challenges for 
microdialysis sampling is that for soluble proteins greater than 10 kDa the RR using 100 kDa 
MWCO PES membranes ranges between 1 and 5% at flow rates of 0.5 and 1.0 μL/min.1  
Considering that proteins and peptides are large in size, their aqueous diffusion coefficients are 
small, thus causing mass transport through the probe to be limited resulting in lower recovery.
7, 17
   
Another challenge for membrane science is the nonspecific adsorption of protein molecules to 
the membrane surface and tubing; this decreases the effective pore size of the membrane and 
thus recovery. Due to the low concentration of certain proteins in vivo, low recovery introduces 
an issue of detection and quantification of these molecules.
7
    
Use of Capture Agents in Microdialysis 
Capture agents have been covalently attached to membranes previously to reduce 
nonspecific adsorption, improve biocompatibility, and for removal of specific molecules.
18, 19
  
The ideal capture agent should have both high binding capacity and a reasonably high 
permeability.
20
  For example, quaternary amine ligands have been used for the removal of 
mammalian viruses, endotoxins, and DNA for biotechnology manufacturing.
21, 22
  Acrylic acid 
polymer brushes have also been used as a cation-exchange ligand.
23
  Also heparin and sulfonated 
polymers imitating heparin (sulfonated poly(styrene)-b-poly(methyl methacrylate)-b-
poly(styrene) and poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly-(vinyl 
pyrrolidone), poly (acrylonitrile-co-acrylic acid-co-vinyl pyrrolidone)) have been used to reduce 
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nonspecific adsorption, improve hemocompatibility, and promote binding of heparin binding 
proteins.
24-26
  
Theory 
It has been previously shown that by adding capture agents to the perfusion fluid the 
diffusive mass transport driving force across the membrane is increased.  This has been shown 
by including antibodies, heparin, and cyclodextrins in the perfusion fluid.
1-4
  These molecules 
increase the diffusive mass transport driving force through the membrane due to the interaction 
between the analyte and the capture agent in the fluid perfused inside the membrane, as well as 
prevent nonspecific adsorption to the membrane surface.
4
  
To understand the factors that alter a capture agent’s ability to improve relative recovery 
enhancement, a hypothetical protein and affinity agent has been used of which the KD, kon, and 
koff can be altered without altering the chemical structure of the protein and the affinity agent.  
This allows the study of how these parameters alter the binding interaction on the interior of the 
membrane surface and how these parameters alter relative recovery.  It has been reported that the 
enhancement in relative recovery (RR) when the affinity agent is added in the perfusion fluid is 
due to the additive effect of the concentration of analyte (A) bound as shown in equation 2.
5
  
RR =
[A]bound+[A]free
[A]external
∗ 100                [2] 
This is due to the analyte affinity agent complex being collected in the perfusion fluid and also 
the decrease in the concentration gradient which increases the analytes flux across the 
membrane.   
The amount of Abound in Equation 2 is a function of KD at equilibrium.  As the KD value 
decreases the amount of analyte needed to saturate the total number of binding sites decreases as 
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well.  This can be seen by the following chemical reaction, where the binding constant is defined 
by Equation 3. 
A+B AB 
KD =
[A]free[B]free
[AB]
                  [3] 
As the KD value decreases the ratio between the concentrations of analyte free in solution 
compared to the analyte bound ([AB]) decreases.  At a set concentration of B the binding sites 
become saturated at a lower concentration at a lower KD value.   
Although microdialysis is a non-equilibrium process due to the continuous flow of the 
perfusion fluid, to achieve maximal relative recovery enhancement under typical low 
concentration and low flux conditions for a protein the desired affinity agent should have a high 
binding affinity and have a low KD value.  One of the challenges with looking only at KD values 
is that these values give no information about the rate at which equilibrium is reached.  This 
information is given by the kon and koff values.  These values can be changed in such a way that 
does not alter the KD values as shown in Table 1, since the KD value is equal to the koff/kon. 
Table 1.  On and Off Rates at a Constant KD Value. 
 
Condition A B C D 
kon (M
-1
s
-1
) 1x10
6 
1x10
5
 1x10
4
 1x10
3
 
koff (s
-1
) 1x10
-2 
1x10
-3
 1x10
-4
 1x10
-5
 
KD (M) 1x10
-9 
1x10
-9
 1x10
-9
 1x10
-9
 
 
Under condition A the kon and koff are larger than at condition D, but with looking at only 
the KD values these two conditions would appear identical.  By looking at these conditions as a 
function of time, the point at which equilibrium is reached is different.  This can be shown using 
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Equation 4 and Equation 5 for association and dissociation rate.
6
  When the analyte that is 
binding is continually added, the association rate dominates the net rate in Equation 6, which are 
the conditions that are occurring when performing microdialysis sampling in vitro.
6-8
   
Association:  
d[AB]
dt
= kon[A]free[B]free             [4] 
Dissociation: 
−d[AB]
dt
= kD[AB]              [5] 
Net Rate =
d[AB]
dt
= kon[A]free[B]free − koff[AB]                 [6] 
When combining the kinetic information with the continual flux of analyte occurring 
across the microdialysis probe equation 7 is formed.
7
 This relates the change in concentration of 
the analyte free in solution as a function of time at a set area of the microdialysis probe, where J 
is equal to the flux (M/s), [A]o and [B]o are the concentration of A and B free in solution, and 
[AB] is the concentration of analyte bound to the affinity agent.  Although Equation 4 and 5 are 
in relation to the change in concentration of analyte bound these can be used to form Equation 7 
because the total amount of analyte A in solution is equal to the amount of analyte A transported 
across the membrane surface minus the amount bound due to the affinity interaction plus the 
amount released due to the dissociation of the analyte-affinity agent complex.  This equation 
shows how the concentration gradient is altered by the addition of an affinity interaction on the 
membrane surface.    
d[A]o
dt
= 𝐽 − kon[A]o[B]o + koff[AB]                            [7] 
As can be seen in Equation 7 the affinity interaction in relation to kon is subtracted from the flux 
term when looking at the free concentration of analyte, A, as a function of time.  As the affinity 
interaction becomes a more dominant term due to a high kon value the amount of free analyte in 
solution approaches zero steepening the concentration gradient across the membrane surface 
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which leads to an increase in mass transport across the membrane.  The release of the bound 
protein in terms of koff is added because the dissociation of the analyte-affinity interaction leads 
to an increase in the concentration of the analyte in solution.  This increase in concentration does 
not affect the concentration gradient because it is carried away convectively due to the flow of 
the perfusion fluid.  From this equation the optimal kinetic parameters can be estimated to 
determine at which kon and koff values the decrease in concentration of free analyte in solution is 
maximized.  This leads to an increase in the concentration gradient which alters the flux as 
shown by Fick’s second law (Equation 8), where J is the flux, Deff is the effective diffusion 
coefficient, l is the length, H is the partition coefficient and c is the concentration.
7
 
𝐽 = [
DeffH
l
] (C10 − C1l)                                                                     [8] 
By changing the concentration gradient (C10-C1l) by lower the concentration of C1l due to 
addition of a capture agent the flux across the membrane is increased due to the binding of the 
analyte dominating the rate equation, shown in Equation 7.
6, 9
   
For VEGF with a molecular weight of 15.5 kDa, a 2.5% relative recovery (from page 
137), and a starting concentration outside the probe of 3,366 pg/mL the calculated flux (J) is 
1.51x10
-15
 M/s.  Assuming a total concentration of heparin 0.1 μM used in heparin affinity 
microdiaysis
10
, the change in concentration as a function of time can be determined.  Based on 
the slope of that line at a set KD value of 100 nM and varying the kon and koff rates the change in 
free analyte (A) over time can be plotted as shown in Figure 2. 
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Figure 2. Change in concentration of A as a function of time related to the koff (s
-1
) and kon 
(M
-1
s
-1
) at a set KD value of 100 nM.    
  
As can be observed from Figure 2 the approximate maximal drop in the free analyte 
concentration occurs approximately at a kon of 2.5 x10
6
 M
-1
s
-1
 and koff of 0.25 s
-1
 with a KD of 
100 nM. This leads to maximal [AB] formation which is desired because this leads to the 
steepening in the concentration gradient which increases flux across the membrane  At low koff 
values the amount of analyte free in solution is greater due to correspondingly lower kon value 
and at the higher koff values and correspondingly higher kon values the amount of analyte free in 
solution calculated exceeds the amount of analyte transported across the membrane so the 
concentration is equal to the flux of analyte across the membrane.  Although these are the 
10 
 
predicted ideal conditions, typically an affinity interaction has either a fast kon (≥1x10
6
 M
-1
s
-1
) 
and a slow koff (≥1x10
-3
 s
-1
) and a high KD (nM) value or a slow kon (≤1x10
6
 M
-1
s
-1
) and a fast koff 
(≤1x10-3 s-1) and a lower KD (μM) value.  For example, CCL2 has a reported kon of 9.97x10
3
 M
-
1
s
-1 
and a koff of 1.39x10
-2
 s
-1 
and cam-related/down-regulated by oncogenes (Domain Fn2) 
(Drosophilia) has a reported kon of 1.58x10
5
 M
-1
s
-1 
and a koff of 2.43x10
-1
 s
-1
, which have 
reported fast koff but slow kon rates and μM KD values.
11, 12
  Also, hepatocyte growth factor has a 
reported kon of 1.0x10
6
 M
-1
s
-1 
and a koff of 1.0x10
-3
 s
-1
 and kininogen-1 has a reported kon of 
1.27x10
6
 M
-1
s
-1 
and a koff of 4.03x10
-4
 s
-1
 which have reported fast kon and slow koff rates and nM 
KD values.
13, 14
  Two proteins which approach the ideal conditions calculated above are fibroblast 
growth factor 2 and stromal cell-derived factor 1 with kon rates of 1.10x10
7
 M
-1
s
-1
, and 2.16x10
6
 
M
-1
s
-1 
and koff rates of 4.30x10
-1
 s
-1
 and 8.30x10
-2
 s
-1
 with KD values of 3.90x10
-8
, and 3.84x10
-
8
.
15, 16
         
Antibodies 
The use of antibodies as capture agents included in the perfusion fluid has been shown to 
increase recovery three to twenty times.
17
  One of the downfalls to using antibodies is that they 
are specific to only one analyte.  To resolve this issue, the use of antibody-immobilized 
microspheres used in flow cytometry applications were added to the perfusion fluid.
17
  This 
allowed for multiple types of antibody-immobilized microspheres to be used, allowing for the 
quantification of multiple analytes and provided a platform for quantification of the analyte.
17
  
This method for enhanced recovery provided one disadvantage in the quantification step.  If the 
analyte concentration was high the microspheres became saturated and thus outside of the 
calibration range of the assay meaning that the sample data was lost.
17
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Heparin    
Another method used to capture multiple analytes is heparin. Heparin is part of a family 
of polysaccharides called glycosaminoglycans (GAG).  GAG’s are a component of the tissue 
extracellular matrix.  In many cases, the binding of proteins to sulfated glycoconjugates, such as 
heparin, have ionic character and depend on the interaction of specific positively charged 
residues.
18
  Yet when purifying a heparin sulfate(HS)-GAG-binding protein, the protein’s 
interaction with a heparin-sepharose column is distinctly different from that of a cation exchange 
column of similar properties.
19
  Heparin on average is comprised of approximately 25 
disaccharide repeating units and has an average molecular weight of approximately 16 kDa.
20
  
Heparin contains α1–4 linked disaccharide repeat units consisting of sulfated uronic acid and 
glucosamine residues, resulting in a negatively charged polydisperse linear polysaccharide.
17
  Its 
major repeating disaccharide unit is trisulfated iduronic acid and glucosamine, but also 
glucuronic acid, and N-acetyl glucosamine.
20
  It is postulated that the conformational flexibility 
of the iduronate residue was central to the specific binding of HS-GAG oligosaccharides to a 
given protein.
19
  Heparin is commonly used as an anticoagulant, and is typically isolated from 
mast cell or mucosa.
19
  Heparin, has binding affinity to various growth factors such as acidic 
fibroblast growth factor (aFGF), vascular endothelial growth factor (VEGF), heparin-binding 
epidermal growth factor, and transforming growth factor-β (TGF-β).21  Heparin is also known to 
bind to interleukin 8 (IL-8), chemokine ligand 2 (CCL2), macrophage inflammatory protein 
1(MIP-1), regulated and normal T cell expressed and secreted (RANTES) and tumor necrosis 
factor α (TNF-α) with nM affinity.22-25  Heparin is also known to bind thrombosponin at the Trp-
Ser-Glu-Trp sequence present in the first type I repeat of thrombospondin.  This sequence is 
widely distributed in the cytokine receptor superfamily (IL3, IL4, IL6, IL7).
18
  Heparin-like 
12 
 
materials have been shown to exhibit good blood compatibility like heparin molecules by 
reducing clotting time and platelet adhesion.
26-30
  Using heparin-immobilized microspheres as an 
additive in the perfusion fluid in microdialysis was shown to increase RR two to five fold for 
aFGF, VEGF, CCL2, and CCL5 (chemokine ligand 5).
31
 
These methods allow for increased recovery for multiple analytes.  Considering that 
cytokines are part of large signaling networks, the measurement of multiple cytokines rather than 
just one single cytokine can provide more relevant biomedical data.
17
  
Covalent Attachment of Capture Agents to the Membrane Surface to Increase Transport   
Considering that the use of capture agents in the perfusion fluid is shown to increase RR 
the question must be asked if RR could be increased by covalently attaching the capture agent to 
the inside of the membrane.  By covalently attaching the capture agent to the membrane 
nonspecific adsorption can be reduced by adding a charged capture agent to the surface, as well 
as adding a reversible binding event to the membrane surface.  With PES membrane surfaces 
proteins can irreversibly bind to the surface leading to membrane fouling.
32-34
  By reducing 
irreversible binding of proteins to the surface this leads to an increase in collection of the analyte 
due to the reduction in fouling.
32-34
  The difference between irreversible binding and reversible 
binding is that reversible binding can be easily removed as compared to irreversible binding.
32, 35
  
By adding the affinity agent to the surface this add reversible binding sites and also blocks 
binding sites that would lead to irreversible binding on the membrane surface.  Initially what 
would be observed, if the fouling occurring on the membrane surface was the same with and 
without the modification, is a decrease in the concentration of the analyte due to the binding of 
the analyte dominating the rate equation shown in Equation 7 and Figure 2.
6, 9
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In Equation 7 for an immobilized affinity agent, J is equal to the flux (mol/cm
2
 s), [A]o is the 
concentration of A free in solution (mol/cm
3
), Bo is the moles of unbound affinity agent per cm
2
, 
and AB is the moles of analyte bound to the affinity agent per cm
2
.  The kon and koff rates are in 
terms of (mol/cm
3
)
-1
s
-1
 and s
-1
 respectively.   
For VEGF with a molecular weight of 15.5 kDa, a 2.5% relative recovery (from page 
137), and a starting concentration outside the probe of 3,366 pg/mL the calculated flux (J) is 
2.26x10
-20
 mol/cm
2
 s.  Assuming a total amount of heparin to be 20 nmol/cm
2
, calculated from a 
reported value of 0.3 mg/cm
2
 heparin bound to a polysulfone flat sheet
27
, the change in amount 
of analyte A in moles as a function of time can be determined with various KD, kon, and koff 
values as shown in Table 2, where Jo is the initial flux calculated above (2.26x10
-20
 mol/cm
2
 s, 
and Ji is the flux calculated with addition of the affinity interaction. 
Table 2.  Change in analyte flux as a function of KD, kon, and koff values.   
 
KD (mol/cm
3
) kon (mol/cm
3
)
-1
s
-1 
koff (s
-1
) Ji (mol cm
-2
s
-1
) J0-Ji (mol cm
-2
s
-1
) 
1 mM 100 0.1 2.26x10
-20
 0 
100 μM 1,000 0.1 2.26x10-20 0 
10 μM 10,000 0.1 2.26x10-20 0 
1 μM  100,000 0.1 2.26x10-20 0 
100 nM 1,000,000 0.1 2.22x10
-20
 4.0x10
-22
 
100 nM 100,000 0.01 2.25x10
-20
 1.0x10
-22
 
10 nM 10,000,000 0.1 1.94x10
-20
 3.2x10
-22
 
10 nM 1,000,000 0.01 2.22x10
-20
 4.0x10
-22
 
10 nM 100,000 0.001 2.26x10
-20
 0 
10 nM 10,000 0.0001 2.26x10
-20
 0 
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As shown in Table 2, with KD values in the mM to μM range the flux of the analyte is not altered 
by the addition of the affinity interaction.  Also with slower koff values (≤0.001 s
-1
) the flux of the 
analyte is not altered even with nM affinity.  The decrease in flux of the analyte occurs for 
interactions with KD values in the nM range with koff rates of 0.01 to 0.1 s
-1
 and corresponding 
kon rates of 1x10
7
 to 1x10
5 
(mol/cm
3
)
-1
s
-1
.  This phenomenon occurs before the saturation of the 
binding sites on the surface occurs.  This leads to an increase in the concentration gradient which 
alters the flux as shown by Fick’s second law shown in Equation 8.  By changing the 
concentration gradient (C10-C1l) by lower the concentration of C1l due to addition of a capture 
agent the flux across the membrane is increased due to the binding of the analyte dominating the 
rate equation shown in Equation 7.
6, 9
  Using the concentration values calculated even at the 
maximum decrease concentration over time, the change in the flux would only be altered by 
1.77%.  This would not lead to a significant enhancement in the RR which explains why initially 
before the binding sites become saturated that the RR is not altered for heparin binding proteins 
(CCL2, aFGF, and VEGF).    
Once the binding sites are saturated, the rate of binding and releasing of the analyte are 
equal so the net rate in Equation 6 is zero.  When the net rate is zero, the relative recovery is not 
altered by the attachment of the affinity agent.  What is interesting is that for analytes that have 
affinity for heparin (aFGF, and CCL2) the relative recovery increased at later collection times 
(hours 3, and 4) this could indicate that by adding reversible binding sites and the reduction in 
irreversible binding sites, that the reduction in irreversible binding sites initially offsets the loss 
due to binding at the surface at the earlier time points and is increasing the relative recovery at 
the later time points due to saturation of the heparin binding sites.  This would also explain why 
the relative recovery of KC/GRO, an analyte that is not known to bind to heparin, increased for 
15 
 
all collections times because the initial phase described above where association is the dominate 
term in the rate equation, is not occurring.   
Reducing Nonspecific Adsorption  
Significance of the Nonspecific Adsorption Problem 
Nonspecific adsorption is a combination of interactions that occur between two 
molecules, which are driven by electrostatic, Van der Waals and other forces; however, the main 
contributor to nonspecific adsorption is hydrophobic interactions.
61
  Nonspecific adsorption in 
implantable devices used to measure the surrounding area can lead to reduced recovery, fouling 
of the device, and inaccurate measurements.
62-64
  Membrane fouling is the term used to describe 
the undesirable deposition of retained particles, colloids, macromolecules, salt etc. at the 
membrane surface or inside the pores.
65
  Fouling of membrane devices occurs through two 
mechanisms of action; the reduction of transmembrane pressure due to concentration 
polarization, and the buildup of material on the surface.
66
  Concentration polarization leads to an 
accumulation of molecules in the mass transfer boundary layer adjacent to the membrane 
surface.
66
  This accumulation of dissolved molecules on the surface can lead to reduced solvent 
activity and thus reduced solvent flow through the membrane.
66
  In microdialysis experiments 
performed in vitro, the solution containing the analyte is typically stirred, which leads to a 
decrease in concentration polarization due to the increase in convection at the membrane surface.   
Importance on Nonspecific Adsorption in Microdialysis 
Another challenge for microdialysis is the nonspecific adsorption of protein molecules to 
the dialysis membrane and tubing, this decreases the effective pore size of the membrane and 
thus recovery.   PES, a commonly used as a membrane material in microdialysis is hydrophobic, 
which enhances interactions with many foulants.
67
  PES membranes also have a high binding 
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affinity for proteins and microorganisms.
67
  In kidney dialysis PES membranes can invoke severe 
blood reactions due to adsorption and transformation of plasma proteins, activation of blood 
cells, adherence of platelets and thrombosis which leads to an increased rate of mortality and 
morbidity for hemodialysis patients.
68
  BSA, fibrinogen and other major proteins are known to 
adsorb onto implanted biomaterials including microdialysis probes.
69
  Since calibration of the 
microdialysis device is in terms of RR the recovery may be altered during or after protein 
deposition, leading to an increase in the error in concentration determined based off of the RR.
69
   
Theory of Nonspecific Adsorption 
Fouling through the buildup of materials on the surface can occur through four modes of 
action: adsorption, pore blockage, deposition, and gel formation.
66
  Adsorption occurs when 
specific interactions occur between the membrane and the solute that creates a monolayer on the 
surface leading to additional hydraulic resistance.
66
  If the degree of adsorption is concentration 
dependent then the increase in concentration polarization will increase the adsorption.
66
  Pore 
blockage can also occur, leading to a reduction in the flux due to the blocked pore.
66
  There are 
four main mechanisms for pore blocking: complete pore blocking, internal pore blocking, partial 
pore blocking, and cake filtration as shown in Figure 3.
66
  Deposition or cake resistance occurs 
when deposited particles on the surface can grow layer by layer leading to increased hydraulic 
resistance.
66
  Gel formation can also occur in the immediate vicinity of the membrane surface 
depending on the level of concentration polarization.
66
  Fouling of the membrane can lead to 
reduction or even loss of recovery of desired analytes.   
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Figure 3.  Mechanisms of fouling, (A) complete pore blockage, (B) partial pore blockage, 
(C) internal pore blockage, (D) cake filtration. 
 
Design of Nonfouling Surfaces 
Highly hydrated chemical groups with optimized physical properties of the surface are 
key to developing effective and stable nonfouling materials for long-term biomedical 
applications.
70
  Polymers grafted to a hydrophobic surface can reduce protein adsorption simply 
because the polymer blocked protein adsorption sites.
70
  Therefore, the blocking agents should 
have groups which are excellent in preventing nonspecific adsorption such as hydroxyl or 
poly(ethylene oxide) groups.
71
  The adsorption and desorption of solutes on membranes will 
depend on many factors such as solution chemistry (pH, ionic strength), physiochemical 
properties, operating conditions, and solution additives.
71, 72
  Specific surface functionalities and 
not the average degree of hydrophobicity or hydrophilicity determine adsorption behavior.
73
  A 
general observation is that proteins adsorb weakly to neutral hydrophilic surfaces, are attracted or 
repelled by charged surfaces, and adsorb strongly to hydrophobic surfaces.
73
  The adsorption 
process can be affected by the protein structure, protein stability, concentration, pH, and ionic 
strength.
74
  The ionic strength of typical perfusion fluids used in microdialysis for Ringer’s 
solution (154 mM NaCl, 5.4 mM KCl, 2.3 mM CaCl2) is 158 mM and phosphate buffered saline 
(PBS) (137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl) is 167.2 mM.  These researchers were 
A 
D 
B 
C 
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able to observe lysozyme adsorption at ionic strengths up to 100 mM.
75
  The adsorption of amino 
acids found in proteins is influenced considerably by moieties presented in the α-position in their 
structures.  Hydrophilic moieties (carboxyl/amide) groups decrease amino acid adsorption on 
bare silica substrates, and hydrophobic phenyl moieties increase adsorption.
73
 
It is hypothesized that the nonfouling ability of both polyhydrophilic and polyzwitterionic 
materials are tightly correlated with a hydration layer near the surface.  A tightly bound water 
layer forms a physical and energetic barrier to prevent protein adsorption on the surface meaning 
that the energy required to displace the water is greater than the energy gained by the protein 
binding to the surface.  Expulsion of water from the surface is the first step in order for protein 
adsorption to occur and if the surface is more hydrophilic then the water is held more tightly.
70
  
When a protein approaches the surface, the compression of the polymer chains causes steric 
repulsion to resist protein adsorption due to an unfavorable decrease in entropy.
70
  Bulk water is 
structured because of hydrogen bonding between the water molecules.
65
  For hydrophobic 
surfaces the orientation of water molecules in contact with a hydrophobic molecule is 
entropically unfavorable.
65
  As a result the entropically unfavorable water molecules are expelled 
into the bulk and the total free energy of the system is reduced leading ultimately to protein 
adsorption.
65
  These hydrophobic interactions can occur up to 80 nm away.
65
 
Reduction in Nonspecific Adsorption in Microdialysis Sampling 
In microdialysis sampling, perfusion fluid additives and modifications to the membrane 
have been made to reduce nonspecific adsorption.  Many modifications to the perfusion fluid 
have been made to increase RR by reducing nonspecific adsorption. The addition of Poloxamer 
407 is one method that has been used is to modify the membrane surface.
76
  Poloxamer 407 is an 
nonionic surfactant with a structure containing hydrophilic polyethylene glycol (PEG) regions 
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and hydrophobic polypropylene glycol regions.
76
  These hydrophobic regions adsorbed onto the 
surface exposing the hydrophilic PEG regions, reducing nonspecific adsorption by 33%.
76
  
Albumins have also been used as a perfusion fluid additive in order to coat the tubing and the 
membrane surface to reduce nonspecific adsorption leading to an increase in RR.  Polysorbate 80 
was also shown to reduce nonspecific adsorption of docetaxel to the polyurethane inlet tubing.
77
  
Other perfusion fluid additives include CHAPS, -cyclodextrin, glucose, and dextran.78   
Methods to Reduce Nonspecific Adsorption 
Methods to reduce nonspecific adsorption focus on one of two approaches: creating a 
surface that repels protein adsorption or a chemical interaction that reduces nonspecific 
adsorption but for both strategies surface hydration is key to reducing nonspecific adsorption.
79
  
One common factor of non-fouling surfaces is their resistance to the release of bound water 
molecules from the surface.  Water that is tightly bound to the polymer surface leads to a 
separation between the proteins in solution and the polymer.
79
  One of the challenges with using 
hydrophilic polymers is their mechanical, thermal and chemical stability.
61
  It has been shown 
that increasing the hydrophilicity of polymers significantly reduced protein adsorption and 
fouling as protein-polymer interactions are reduced.
61
  Many methods have been used to repel 
protein adsorption by changing the properties of the surface.  Some methods take the approach of 
increasing the hydration of the surface, these include: zwitterionic hydrogels, PEG and 
oligoethylene glycol (OEG). Other methods use blocking agents to block sites of nonspecific 
adsorption from analytes of interest.  There are two main types of surface modifications:  
chemical and physical modifications.
61
  Examples of physical modifications include exposure to 
flame, plasma radiation, and ion beams, and chemical modification include chemical reactions.
61
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Hydrophilic Polymers 
Hydrophilic surface modifications to hydrophobic membranes can reduce the 
hydrophobic interaction between the protein and the polymeric membrane surface.
61
  It has also 
been shown that polymers incorporating hydrophilic groups also showed good blood 
compatibility.
24
  A nitrogen based plasma system has been used to modify PES membranes 
making the surface more hydrophilic leading to an increase in water flux and reduced protein 
fouling.
80
  Many other types of materials have been used to increase the hydrophilicity of the 
surface by hydrogen bonding, including, tetraglyme
81
, dextran
82
, mannitol
83
, polyamines 
functionalized with acetyl chloride
84
, PEG-mimetic peptoids
85
, and natural and synthetic 
peptides.
86, 87
 
Other Covalent Modifications to Reduce Nonspecific Adsorption 
Another approach is to use adsorbed protein films.  These have been shown to be 
reasonable non-fouling surfaces for proteins in solution because proteins typically adsorb in 
monolayers.  This is caused by the retention of hydration water by adsorbed protein molecules, 
preventing close interactions with the proteins in solution.
79
  
Many different covalent modifications have been made to membranes in order to reduce 
nonspecific adsorption.  Photo-induced graft polymerization has been used to covalently attach a 
phospholipid analog and was shown to reduce platelet adhesion to the membrane.
48
   
Photografting has also been used to attach acrylic acid which is negatively charged over a wide 
range of pH and was shown to reduce organic fouling and biofouling.
88
   
Enzymatic Modification of Membrane Surfaces 
Enzymes have also been used to facilitate the modification of membrane surfaces.  The 
ideal enzyme to use for modification of membrane surfaces should have low cost of production, 
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inexpensive co-factors and substrates, be stable under reaction conditions, ability to exert its 
catalytic activity at high reaction rates under desired reaction conditions, and broad substrate 
specificity.
89
  One of the enzymes used to modify membrane surfaces is laccase.  Laccase is an 
enzyme that produces free radicals from phenolic acids using oxygen from air as an oxidant and 
producing water as the only by-product.
67
  It is known to produce either a network or brush like 
structure depending on the substrate and reaction conditions used.
67
   
Laccase 
Laccases are copper containing polyphenol oxidases that oxidize polyphenols, methoxy-
substituted phenols, and diamines, and using molecular oxygen as an electron acceptor.
90
  
Laccases induce the oxidation of C-O, C-C bonds, oxidative dimerization alicyclic esters, 
hydroxystilbenes, and the combination of oxidation followed by Diels-Alder reaction.
90
  
Laccases are more stable at or near neutral pH, and below room temperature but have a range of 
stability between pH 5-8 and up to 30°C.
89
  Thermal inactivation is the main cause of 
denaturation, refolding can occur but is slow (3-12 hours) compared to 5-60 minutes for pH 
denaturation.
89
  Laccase Trametes versicolor has the highest redox potential among laccases (785 
mV vs standard hydrogen electrode) which is correlated with high activity.
89
  Laccase is a 
monomer, organized in three sequentially arranged domains and has dimensions of about 65 x 55 
x 45 Å
3
.
91
  Laccase in nature is involved in the wound response and the synthesis of lignin.
91
   
Laccase contains a T1 (type-1) copper and a T2, T3 copper trinuclear cluster.  The T1 
copper is the primary oxidation site, and the T2/T3 copper cluster being the site at which the 
reduction of molecular oxygen takes place.
91
  The enzyme catalyzes the one-electron oxidation 
of four reducing-substrate molecules followed by the four-electron reduction of molecular 
oxygen to water.
91
  Then the reduction of molecular oxygen is accompanied by a one-electron 
22 
 
oxidation of reducing substrates.
91
  This catalytic reaction starts with the abstraction of electrons 
from the substrate by the T1 copper and subsequent reduction of the T1 Cu
2+
 to T1 Cu
+
, followed 
by the internal electron transfer from T1 to the T2/T3 copper cluster, and finally the binding and 
subsequent reduction of an oxygen molecule to divalent oxygen at the T2/T3 copper cluster.
89
  
The substrate binds in a small negatively charged cavity near the copper T1 site.  The negative 
charges located at this site may have functional significance since they could stabilize the radical 
cation products that are formed during the catalytic cycle.
91
  The oxygen-reducing site at the 
T2/T3 cluster has access to solvent through two channels, which lead to the T2 copper and T3 
copper sites.
91
  In between the two T3 coppers, there is an oxygen ligand, either a OH
-
 or O
-2
 
molecule, that coordinates with the type-2 Cu and type-3 Cu.
91
  The reoxidation of the coppers 
occurs at a rate of 5 x10
6 
M
-1
sec
-1
.
91
  The overall outcome of the catalytic cycle is the reduction 
of one molecule of oxygen to two molecules of water and the concomitant oxidation of 4 
substrate molecules to produce 4 radicals.
91
   
The use of laccase to generate phenolic acid polymers and to attach phenolic compounds 
to the surface of PES has been shown to reduce nonspecific adsorption and as shown in this 
dissertation that it can be used to add functional groups onto the surface to covalently attach 
other molecules.  This is due to two reaction types that occur, the grafting reaction of monomer 
onto the membrane surface and reaction of the monomers to form homopolymer in solution.
92
  
Laccase from Trametes villosa has also been reacted with 4-hydroxybenzoic acid (4HBA) to 
form a polymer with a number average molecular weight (Mn) of 8,500 Da for the 4 hour 
reaction and 8,400 Da for the 24 hour reaction with a polydispersity index (PDI) of 2.06 and 2.12 
for the 4 and 24 hour reaction times respectively.
93
  4-hydroxybenzoic acid (4HBA) has been 
shown to be added to a PES surface using laccase trametes versicolor from with coverage in the 
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range of hundreds of mg/m
2 
which is on average more than a monolayer.
94
  This modification has 
also been shown to reduce BSA adsorption on PES flat sheet membranes and the average flux of 
the base membrane was never reduced more than 20% by the addition of the polymer.
92, 94
  The 
reasons for these researchers choosing 4HBA is that it will add ionic and hydrogen bond-forming 
properties to the PES membranes as well as there is only one hydroxyl group which leads to 
growth of the chains mostly in one direction.
92
  At pH 4 the grafting yield after 2 hour 
modification was 4 μg/cm2, at pH 5 it is 11.7 μg/cm2 and at pH 6 12.7 μg/cm2.92  This is 
attributed to the ionization of 4HBA at higher pH, which leads to a lower oxidation potential, and 
thus higher reaction rate and grafting yield.
92
  The adsorbed amount of BSA decreases with 
increasing grafting yield and is close to 0 after 8 hours of modification at 28.8 mM 4HBA.
92
  
Pycnoporus coccineus and Myceliophthore laccases have also been used to graft 4HBA to 
poly(phenylene oxide)s.
95
  To further study the laccase catalyzed reaction these researchers 
studied consumption of oxygen when laccase was in the presence of 1-naphthol using a Clark-
type polarographic oxygen electrode and were able to determine KM and Vmax for the reaction.
96
  
These were determined based on the knowledge that the initial consumption rate of dissolved 
oxygen is equal to one-fourth the consumption rate of 1-naphthol due to the 1 to 4 stoichiometric 
ratio in the polymerization reaction.
96
   
Characterization of Polymer Surfaces 
Many techniques are used to characterize polymer surfaces.  These include techniques to 
study how the physical properties of the surface are changed, how the surface is changed 
chemically, and how molecules interact with the surface.  Commonly studied physical properties 
are hydrophobicity, thermal properties, and morphology.  Techniques commonly used to study 
the chemical properties of a surface are attenuated total reflectance Fourier transform infrared 
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spectroscopy (ATR-FTIR), x-ray photoelectron spectroscopy (XPS), and matrix assisted laser 
desorption ionization spectroscopy (MALDI).  Absorption of molecules onto the surface is also 
commonly measured using protein adsorption.   
Techniques used to Study the Chemical Properties of a Polymer 
ATR-FTIR 
ATR-FTIR is a powerful technique that uses infrared spectroscopy to study the chemical 
functionalities at the surface.  This technique allows for the investigation of solids and liquids 
without further sample preparation due to the phenomenon of total internal reflectance.  This 
generates an evanescent wave due to the repeated reflection of the infrared radiation interacting 
on an optical crystal of high refractive index.
97
  This technique has been used to identify 
functional groups present on surfaces, to confirm modifications made, and to study the buildup 
of foulants on a surface.
97
  ATR-FTIR was used to confirm the synthesis of PES hollow fiber 
membranes.
98
  Many researchers have also used ATR-FTIR to confirm a modification.
52, 73, 88, 90, 
99-104
  Some researchers have also used ATR-FTIR to study the buildup and removal of foulants 
on the surface.
87, 105
   
XPS 
XPS is an analytical technique used to characterize different chemical forms of elements 
within the top 10 nm of a surface.
106
  Depth profiling can be performed using C60 or Ar as well as 
co-sputtering with both C60 and Ar.
107
  Analysis of a sample is typically performed by first 
performing a survey scan which is a low resolution scan used to identify the elements present in 
the sample.  After the survey scan, high resolution scans are performed for the specific elements 
present in the sample.  From these high resolution scans the different functional groups can be 
seen as different peaks.  Using peak fitting software, the area and intensity of these peaks can be 
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determined at specific binding energies.  With this information and the known response factors 
for each element, the different percentages of each functional group can be calculated.  This 
calculation is performed by taking the area multiplied by the response factor divided by the total 
of the area time response factor for all peaks.  This value is then multiplied by 100 to convert to a 
percentage.  These percentages can then be compared.  XPS has been used to monitor the 
addition of coupling agents needed to induce the bond formation between a fiber and a polymer 
matrix.
108
  XPS has been used to analyze modifications to membranes.
24, 61, 90, 109, 110
  By using 
XPS the characteristic types of atoms and bonds for the capture agent and 4HBA will be an 
indication of successful coupling.   
Analysis of Polymer Samples to Determine Molecular Weight Information 
Polymers formed in a polymerization reaction are by nature complex due to the 
distribution of molecular weights present.  One way to characterize these distributions is to 
calculate the number average molecular weight (9), and weight average molecular weight (10) 
which then in turn can be used to calculate the polydispersity (11),     
𝑁𝑢𝑚𝑏𝑒𝑟 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 =
Σ𝑁𝑥𝑀𝑥
Σ𝑁𝑥
              [9] 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 =
Σ𝐶𝑥𝑀𝑥
Σ𝐶𝑥
            [10] 
𝑃𝑜𝑙𝑦𝑑𝑖𝑠𝑝𝑒𝑟𝑠𝑖𝑡𝑦 =
𝑊𝑒𝑖𝑔ℎ𝑡 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡
𝑁𝑢𝑚𝑏𝑒𝑟 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡
           [11] 
where Nx is the number of molecules of Mx size, Mx is molecular weight, and 𝐶𝑥 = 𝑁𝑥𝑀𝑥.  To 
calculate these values two techniques are typically used, mass spectrometry, and size exclusion 
chromatography.   
Size exclusion chromatography (SEC) is a technique that separates molecules based on 
their size (hydrodynamic volume) at a set solvent strength and typically a pure solvent.
111
  The 
hydrodynamic volume depends on a variety of factors, including interactions between solvent 
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and polymer molecules, chain branching, restricted rotation caused by resonance, and 
conformational effects arising from the polarity, and steric bulkiness of the substituent groups.
112
  
Unless a molar mass sensitive detector is used SEC requires calibration using standards of 
known molar mass distribution.  These standards are typically polyethylene, PEG or polystyrene.  
In order to perform this technique, the standards need to mimic the physiochemical properties of 
the sample.  From these standards a calibration curve is formed from the relationship between the 
log of molecular weight at peak max and the retention time.
113
  A commonly used detector for 
SEC is a light scattering detector which is widely used for obtaining weight average molecular 
weights between 10-10,000 kDa.
112
  A challenge for SEC is that highly branched samples have 
abnormal SEC elution behavior this is due to large molecules spending too much time diffusing 
in and out of the column packing creating an Argentinean bolas effect (entanglement of a part of 
the macromolecule in the column packing) and sieving in the voids between packing spheres.
114
  
One way to help with this problem is to use multiple separations for branched polymers.
114
  An 
example of using multiple separations is to perform SEC/MALDI where the sample is 
fractionated into individual fraction that have a polydispersity index (PDI) <1.07, and then 
analyzed using MALDI-TOF.
115
  Also the information obtained from the MALDI-MS can be 
used to create a calibration curve for SEC making the calibration more accurate.
111
  An added 
advantage to using this technique is that structural data about monomers, repeating units and end 
groups are also provided by SEC/MALDI.
115
 
For polymers with molecular weights less than 50,000 Da, end group analysis, titration, 
elemental analysis, radioactive tagging, and spectroscopy (IR, NMR (nuclear magnetic 
resonance)), can be used to determine molecular weight information.
112
  In order to use end 
group analysis for Mn the polymer cannot be branched.
112
  It also must be noted that in a linear 
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polymer there are twice as many end groups as polymer molecules, and that if the polymer 
contains different groups at each end of the chain and only one characteristic end group is being 
measured, the number of this type is equal to the number of polymer molecules.
112
 
When characterizing polymers using mass spectrometry, MALDI, or liquid 
chromatography electrospray ionization (LC-ESI-MS) are typically used.  MALDI involves 
embedding the analyte in a matrix.  The matrix being a compound that absorbs at the wavelength 
of the laser.  This energy is then transferred from the matrix to the analyte leading to ionization 
of the analyte molecule as well as desorption of the matrix and the analyte.  MALDI-TOF (time 
of flight) MS (mass spectrometry) has been shown to be able to detect synthetic polymers in 
excess of 1,000 kDa.
111
  One of the strengths of using MALDI-MS is in the simplicity of the 
mass spectra which contains mostly singly-charged quasi-molecular ions and relatively high 
tolerance for contamination.
111
  In order to use MALDI-MS to determine the number average 
molecular weight, weight average molecular weight, and the polydispersity, the ionization 
efficiency needs to be ideally the same for each molecular weight of the polymer in order for the 
intensity to be used.  In order for these requirements to be fulfilled there needs to be a narrow-
distribution of homo-polymers with a polydispersity of approximately 1.2 or less.
111
  One way to 
overcome the issue of complex polymer systems with several mass distributions is to use a 
separation technique in conjunction with MALDI-MS.
111
  
LC-ESI-MS can also be used to analyze polymers.  ESI works by passing a liquid 
through an intense electric field that disperses the sample into a fine spray into a bath gas which 
evaporates the charged droplets producing gas-phase ions.  These ions are then sent into the mass 
analyzer.  Some of the issues with using ESI for polymers are the insolubility of polymers in 
ESI-compatible solvents, and their electroneutrality prohibits ion formation using the ESI 
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mechanism.
111
  The ability of ESI to produce multiply-charged ions extends the mass range but 
this can lead to complexity in the mass spectra for even narrowly dispersed polymers.  To reduce 
this complexity coupling the ESI to a separation technique can be done.   
Techniques used to Study the Interaction between the Surface and the Environment 
For surfaces that are placed in a biological sample a commonly measure parameter is 
protein adsorption.  Commonly used proteins solutions are bovine serum albumin (BSA), 
lysozyme, and serum.  Protein adsorption can be measured using a variety of methods such as 
surface plasmon resonance, quartz crystal microbalance and reflectometry but these techniques 
require specialized equipment.  A commonly feasible method for most labs to measure protein 
adsorption onto a surface is by difference between a solution containing a known protein 
concentration and the surface, and a solution containing the same known concentration of 
protein.   This change can be measured using absorbance value at 280 nm
61, 67, 92, 116-120
, using the 
bicinchoninic assay (BCA)
121-126
, or using fluorescently labeled proteins
99, 103, 127, 128
.  Another 
method is to desorb the proteins bound to the surface using sodium dodecyl sulfate (SDS) and 
sodium hydroxide.
87
   
The difference method using the absorbance at 280 nm uses the intrinsic absorbance from 
aromatic amino acids present in the protein, mostly tyrosine and tryptophan.
129
  It is necessary to 
use standards of the protein you are interested in, in our case BSA and lysozyme, because the 
molar absorptivity of the each protein is different due to the different amount of aromatic amino 
acids as well as how exposed those amino acids are.  One of the dawbacks to this method is that 
as the time of incubation of the surface with the protein solution increases, the protein denatures 
exposing more of the aromatic residues which thus leads to an increase in the absorbance value 
at 280 nm although the protein concentration has not changed.  Another consideration that must 
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be made is that other compounds can also absorb light at 280 nm.  In our case the PES itself in a 
solution of PBS at pH 7.4 absorbed at 280 nm.  This was corrected for by performing a 
measurement of a solution containing only PBS and the PES membranes.  The change in 
absorbance per unit area was then calculated from this information and subtracted from the 
change in absorbance per unit area from the membranes placed in the protein solution. 
The difference method using the BCA assay is a colorimetric assay that uses the 
reduction of Cu
2+
 to Cu
+
 by proteins in an alkaline medium with detection of the Cu
+
 by 
bicinchoninic acid.
130
  The first step involves the chelation of copper (Cu
2+
) in an alkaline 
medium to form a blue complex in the presence of sodium potassium tartrate by the biuret 
reaction.
130
  The next step involves bicinchoninic acid which reacts with the cuprous cations 
formed in step one generating a purple colored product from the chelation of two molecules of 
BCA with one cuprous ion.
130
  The BCA/copper complex displays a strong linear absorbance at 
562 nm with increasing protein concentration.
130
  The BCA color formation is strongly 
influenced by cysteine, tyrosine and tryptophan but the universal peptide backbone also 
contributes to the color formation.
130
  BCA is dependent on the amino acid composition of the 
protein therefore when using a BSA standard the concentrations are relative and not absolute.
130
  
Also as incubation time of the surface with the protein solution increases, the protein structure 
will change which can also affect the concentration calculated using the calibration curve.   
Using a FITC-labeled protein to measure protein adsorption by difference, one must 
consider the effect the label will have on the protein structure.  FITC-labeling occurs through the 
amine residues on the proteins by incubating the FITC and protein in a solution with a pH of 9.0 
or greater, followed by separation of the free FITC from the FITC-labeled protein.
131
  The 
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protein adsorption is then calculated based on the difference in fluorescence intensity from a 
solution containing the surface and the solution.   
Another type of method to measure protein adsorption is a method that removes the 
adsorbed protein from the surface using SDS and NaOH.  In this method the surface is placed in 
a solution containing the protein of interest for a set amount of time.
87
  The surface is then 
removed and placed in a solution containing SDS and NaOH which desorbs the protein bound to 
the surface.  Then the concentration of protein is measured in the SDS/NaOH solution.
87
  One of 
the disadvantages to this method is that depending on the interactions between the surface and 
the protein the removal with SDS and NaOH may become more or less effective.  This can 
become an issue when comparing a modified surface to an unmodified surface, especially if the 
modification is reducing nonspecific adsorption.  This can falsely lead to an increase in protein 
adsorption when in fact the removal was more effective on one surface versus another. 
Another factor in measuring protein adsorption is the amount of time that the surface is 
incubated in the protein solutions.  Commonly used incubation times are 1 hour,
98, 132
 2 hours,
52, 
99, 100
 3 hours,
122
  and 24 hours
116, 119, 120, 133
.  
Objective 
The work to be described in this dissertation has two main objectives.  The first objective 
seeks to address the challenges with protein adsorption onto the dialysis membrane.  This 
nonspecific adsorption onto the dialysis membrane can severely affect the capabilities to recover 
important signaling proteins of interest.  This objective was met by covalently modifying the 
membrane by attaching phenolic compounds onto the membrane and testing the RR of five 
different cytokines and lysozyme.  The second objective focuses on attaching an affinity agent, 
heparin, onto the membrane surface, increasing the mass transport across the membrane by 
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reducing irreversible adsorption.  The analytes chosen are CCL2, aFGF, and VEGF.  The reason 
for choosing these analytes was to test if the off rates (koff) would have an effect on the RR 
enhancement.  The koff is defined as the rate of dissociation between two molecules with units of 
s
-1
.  CCL2 has a reported slow koff rate of (1.64 ± 0.66) x 10
-3
 s
-1
. 
134
  VEGF and aFGF have 
reported fast koff rates of 0.10 ± 0.03 s
-1
 and 0.10 ± 0.03 s
-1
.
134
  Also, aFGF, CCL2, and VEGF 
have different isoelectric points (pI), of 5.7, 9.3 and 8.5, respectively.  Because heparin is highly 
sulfonated, it is highly negatively charged, which also may be a factor in RR enhancement due to 
the charge-charge interactions between the protein and heparin.  Covalently attaching heparin 
onto the membrane surface and measuring the change in recovery of three heparin binding 
proteins has met this objective.     
  
32 
 
CHAPTER 2.  MODIFICATION OF PES FLAT SHEETS AND MICRODIALYSIS 
MEMBRANES WITH 4-HYDROXYBENZOIC ACID POLYMERS TO REDUCE 
NONSPECIFIC ADSORPTION AND IMPROVE RELATIVE RECOVERY  
 
Introduction  
Due to the chemical and physical stability of polyethersulfone (PES), PES is widely used 
in membrane science.  One of the challenges with using PES is that it is hydrophobic in nature.  
For that reason, when PES is placed in a solution, it leads to an increase in nonspecific 
adsorption on the surface.  Previous research has shown that polymers grafted to a hydrophobic 
surface can reduce protein adsorption simply by nonspecifically blocking protein adsorption 
sites.
70
  Therefore, the polymer should have groups which prevent nonspecific adsorption, such 
as hydroxyl or poly(ethylene oxide) groups.
71
  By modifying the surface with a hydrophilic 
polymer, 4HBA, the surface becomes more hydrophilic but the chemical and physical properties 
of PES are not changed.  This chapter addresses a method of attaching 4HBA-initiated polymers 
onto the surface using the enzyme laccase, and the characterization of nonspecific adsorption and 
its effect on RR in microdialysis.  Initially, experiments were performed on PES flat sheets to 
confirm the modification with 4HBA polymers using the enzyme laccase, and to analyze protein 
adsorption onto the surface.  After characterizing this reaction onto flat sheets this method was 
then applied to hollow fiber microdialysis membranes.   
Materials and Methods  
Materials 
Laccase form Trametes versicolor, sodium acetate, fluorescein isothiocyanate dextran 
4,000, fluorescein isothiocyanate dextran 10,000, fluorescein isothiocyanate dextran 20,000 and 
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methyl orange were purchased from Sigma Aldrich (St. Louis, MO), 4-hydroxybenzoic acid was 
purchased from TCI (Portland, OR).  3-chloro-4-hydroxybenzoic acid, and 2-5-
dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill, MA).  HPLC grade methanol 
and water were purchased from Fisher Scientific (Waltham, MA).  Glacial acetic acid was 
purchased from VWR international (Radnor, PA).  NAP-25 Sephedex G-25 column were 
purchased from GE healthcare (Chicago, IL).  Bovine Serum Albumin fraction V, was purchased 
from Rockland (Pottstown, PA) and was certified immunoglobulin and protease free.  Lysozyme 
was purchased from MP biomedicals (Solon, OH).  100 kDa PES flat sheet membranes (UE50) 
were purchased from Sterlitech (Kent, WA).  Fluorescein isothiocyanate isomer 1 was purchased 
from Alfa Aesar (Haverhill, MA).  Dibasic sodium phosphate (ACS grade) was purchased from 
EMP (Howell, NJ).  Sodium chloride bioXtra grade, potassium chloride (99.0%), and monobasic 
potassium phosphate (ACS grade) where purchased from Sigma Aldrich (St. Louis, MO).  CMA 
20 microdialysis probes were purchased from Harvard Apparatus (Holliston, MA).  CCL2, and 
TNF- optiEIA ELISA kit was purchased from BD bioscience (San Jose, CA)  Recombinant rat 
KC/GRO, and mouse aFGF, and VEGF Duo set ELISA kits were purchased from R&D systems 
(Minneapolis, MN).Recombinant mouse FGF1 was purchased from Sino Biologicals (Beijing, 
China) and recombinant mouse VEGF was purchased from Life Technologies (Carlsbad, CA).     
Addition of 4HBA onto PES Flat Sheets 
Modification of 100 kDa polyethersulfone (PES) flat sheets were performed with a 
solution containing 28.8 mM 4HBA or 3Cl4HBA, and 0.5 U/mL of laccase from Trametes 
versicolor that were dissolved in 0.1 M sodium acetate buffer pH 5.0.  The solution was filtered 
using a 0.2 μm PES filter and the membranes were placed in the solution for 24 hours on a plate 
shaker at room temperature.  Following modification, the membranes were placed in a solution 
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of 0.1 M sodium acetate buffer pH 5.0 at room temperature overnight.  The membranes were 
then analyzed using XPS. 
XPS Methods for PES Flat Sheets 
  Four different control solutions were used.  The 4HBA control contained 28.8 mM 
4HBA in 0.1 M sodium acetate at pH 5.0.  Laccase control contained 0.5 U/mL laccase in 0.1 M 
sodium acetate at pH 5.0.  The 3Cl4HBA control contained 28.8 mM 3Cl4HBA in 0.1 M sodium 
acetate at pH 5.0.  Sodium acetate control contained only 0.1 M sodium acetate at pH 5.0.  The 
procedure for the controls was the same as the modified flat sheet membranes. Three 1 cm x 1 
cm flat sheet 100 kDa PES membranes was placed in these solutions and each one was analyzed 
individually.  Then one from each group of flat sheet membranes was analyzed in three different 
areas.  XPS high resolution spectra for C1s, O1s, and Cl 2p, and survey scans were performed.   
ATR-FTIR Method 
A separate set of membranes where prepared as stated above but allowed to react in the 
4HBA polymerization solution for 1, 2, 3, and 4 days.  The membranes were then placed in a 
desiccator overnight to dry the membrane before analysis with the ATR-FTIR.  
Protein Adsorption Methods 
FITC-labeling of both BSA and lysozyme was performed by placing 400 μg of FITC into 
10 μL of DMSO, and dissolving 4 mg of BSA or lysozyme into 990 μL of 0.1 M phosphate at 
pH 8.0.  These two solutions were then combined and incubated at 37°C for 2 hours.  Then, the 
solution was filtered using a NAP-25, Sephedex G-25 size exclusion column to separate the 
FITC-labeled protein from the free FITC.  The concentration of FITC-labeled protein was 
determined based on the absorbance at 280 nm. Later, the membranes were then placed in a 
solution of FITC-BSA (74 μg/mL) or FITC-lysozyme (5.5 μg/mL) and a solution without 
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membranes (control solution) were incubated for 48 hours.  Then, fluorescence measurements 
were made using an excitation wavelength of 485 nm, and the emission was measured from 500-
650 nm.  As a result, the emission maxima were between 517 nm and 520 nm for FITC-BSA and 
for FITC-lysozyme were between 515 nm and 517 nm.  To determine the concentration, a 
calibration curve was made for both FITC-BSA and FITC-lysozyme using the stock solutions 
from above.  After the concentration was determine, the difference between the concentration of 
the control solution and the solution containing the membranes was calculated.  Then, the 
difference was used to determine the amount of protein adsorbed per unit of surface area using 
Equation 12. 
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝐴𝑑𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 (𝜇𝑔 𝑐𝑚2⁄ ) =
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝜇𝑔 𝑚𝐿)∗𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿)⁄
𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑐𝑚2)
        [12] 
 
Attachment of 4HBA onto Microdialysis Membranes 
For the modification of the PES microdialysis membranes a solution containing 28.8 mM 
of 4HBA, and 0.5 U/mL of laccase from Trametes versicolor that was dissolved in 0.1 M sodium 
acetate buffer pH 5.0.  Then, the solution was filtered using a 0.2 μm PES filter and perfused at a 
rate of 1 μL/min for either 2 hours or 24 hours.  Following modification, the probe was flushed 
with 0.1 M sodium acetate buffer pH 5.0 overnight at a flow rate of 3 μL/min.  Following 
modification, the microdialysis membranes were either used for a relative recovery experiment 
or cut longitudinally and the inside was analyzed for reaction with 4HBA using XPS.  An initial 
survey scan was performed to determine the elements present in the sample.  This was followed 
by high resolution scans of C1s, O1s and S2p to determine the binding energies present and the 
percentages of those binding energies.   
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Relative Recovery Determination 
FITC-Dextrans 
Initially an experiment was performed to determine if the presence of laccase alters the 
membrane in a way that changes the recovery of FITC-4 and FITC-10.  The microdialysis probes 
were placed in a stirred solution containing 0.5 U/mL laccase in sodium acetate pH 5 for 2 hours, 
and perfused for 2 hours in laccase solution.  Relative recovery of FITC-4 and FITC-10 was 
determined using a CMA 20 microdialysis probe at a flow rate of 1 μL/min with a perfusion fluid 
of 4% (w/v) Dextran 500 in Ringer’s solution (154 mM NaCl, 5.4 mM KCl, and 2.3 mM CaCl2) 
at pH 7.2-7.4.  The probe was placed in a solution of either 500 μM FITC-4 or 200 μM FITC-10 
in perfusion fluid and samples were collected every 20 minutes for a total of 60 minutes.  Then, 
the absorbance values were measured in triplicate for each sample at 493 nm, and concentrations 
were determined based off a calibration curve measured that day.   
 To test the impact of the modification with 4HBA, FITC-4, FITC-10 and FITC-20 RR 
was determined.  This experiment was performed using a CMA 20 microdialysis probe modified 
for 0, 2 and 24 hours with 4HBA at a flow rate of 1 μL/min using PBS at pH 7.4.  The solution 
the probe was placed in contained 500 μM FITC-4, 200 μM FITC-10 or 100 μM FITC-20 in PBS 
pH 7.4, and samples were collected every 20 minutes for a total of 60 minutes.  Absorbance 
values were measured in triplicate for each sample at 493 nm, and concentrations were 
determined based off a calibration curve measured the same day.   
Proteins  
After testing RR of FITC-4, FITC-10, and FITC-20, RR was analyzed for lysozyme using 
control, 2 hour and 24 hour 4HBA modified membranes using the same microdialysis probes as 
above.  RR of lysozyme was performed using 500 μg/mL of lysozyme with a perfusion fluid of 
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PBS at pH 7.4 at a flow rate of 1 μL/min.  Samples were collected every 30 minutes for a total of 
2 hours and were analyzed using a standard BCA assay.  Next RR of CCL2, VEGF, TNF-, 
KC/GRO (keratinocyte chemoattractant/ growth regulated oncogene), and aFGF were 
performed.  To test the RR of these analytes the probes were placed in a solution containing 
6,000 pg/mL of CCL2, 800 ng/mL of aFGF, 4,000 pg/mL KC/GRO, 5,000 pg/mL TNF- or 200 
ng/ml of VEGF in PBS 0.1% BSA at pH 7.4.  These concentrations were chosen in order to 
observe concentrations in the dialysate that are within the detection range for the corresponding 
ELISA.  The perfusion fluid was prepared using PBS 0.1 % BSA at pH 7.4 and perfused at 1 
μL/min, and the samples were collected every hour and analyzed using a standard CCL2, aFGF, 
KC/GRO, TNF- or VEGF ELISA.  
Results and Discussion 
Addition of 4HBA Polymers onto PES Flat Sheets  
After modification with 4HBA and laccase using the procedure described above, images 
of the membrane were taken.  As shown in Figure 4, upon the addition of 4HBA polymer onto 
the PES flat sheets the membrane surface becomes browner in color which is due to the 
oxidation of the 4HBA polymer on the surface.  The results from XPS analysis are shown in 
Figure 5 and Tables 3 and 4.  In Figure 5(A), the high resolution scan of C1s shows the presence 
of 3 peaks for the 4 different controls (laccase control, 4HBA control, 3Cl4HBA control, and 
sodium acetate control); these are the C-C/C-H peak at 284.77 eV, the ether linkage (C-O-C) at 
286.23 eV and the C-S peak at 288.81 eV.  For the 4HBA modified and 3Cl4HBA modified, 
there is a peak present between C-O-C and C-S which corresponds to the carboxylic acid 
functional group at 287.85 eV.  This indicates that the membrane is modified because the 
controls (4HBA control, laccase control, 3Cl4HBA control, and sodium acetate control) do not 
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contain carboxylic acid functional groups.  In Figure 5(B), the Cl2p high resolution scan showed 
the presence of C-Cl peak at 200.32 eV and 201.92 eV which indicates the attachment of 
3Cl4HBA.  Also, the C-Cl peaks are not present in the 3Cl4HBA control indicating the 
3Cl4HBA does not adsorb to the surface, but is covalently bound.  In Figure 5(C), the O1s high 
resolution survey scan shows the presence of 2 peaks for the 4 controls; these are from the O-C 
(531.72 eV) and O-S (533.35eV) functional groups.  In the 4HBA and 3Cl4HBA modified flat 
sheet membranes, there is a merging of these 2 peaks indicating the presents of a third functional 
group, possibly a carboxylic acid functional group.  In Figure 5(D), the survey scan for the 
4HBA modified, 3Cl4HBA modified and the sodium acetate control is shown.  From the 
information obtained from the high resolution spectra, the percentages of each functional group 
was calculated and tabulated in Table 3 for one flat sheet analyzed in 3 different areas and in 
Table 4, for 3 different flat sheets. 
For the laccase control, the C-C, C-O-C, O-C and O-S percentages were significantly 
different than the other control membranes.  This is most likely due to laccase being a protein, 
and proteins are known to adsorb onto PES surfaces.  For the 4HBA modified membranes, due to 
the O-S bond only being present in PES, the O-S decreased.  For 4HBA, the COOH functional 
group was also present which is the end group of the 4HBA polymer at a percentage of 
8.62±0.74%.  For 3Cl4HBA, the C-Cl doublet was present a percentage of 3.50±0.71% and 
1.75±0.36%, the COOH functional group was present at 5.10±1.63% and the O-S decreased.  
Results in Table 4, for three different locations on one flat sheet show similar trends to the results 
in Table 3 indicating uniformity in the modification procedure.  For the 4HBA modified flat 
sheets, the COOH functional group appeared at a percentage of 6.82±2.19% which was not 
present in any other control flat sheets.  Also, the O-S and C-O-C functional group was 
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significantly less than the control membranes.  For the 3Cl4HBA modified membranes, the 
chlorine doublet for C-Cl was present at a percentage of 2.88±0.24% and 1.44±0.12%, and the 
COOH functional group at 5.10±1.82%.  Also, the C-O-C percentage increased and the O-S 
environments decreased compared with the control membranes.  
 
 
Figure 4.  PES membranes before and after 4-hydroxybenzoic acid modification.  (A) PES, 
(B) sodium acetate control, (C) laccase control, (D) 4HBA control, (E) 1 day 4HBA 
modification, (F) 2 day 4HBA modification (G) 3 day 4HBA modification, (H) 4 day 4HBA 
modification.  
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Figure 5.  XPS spectra for PES flat sheets. XPS overlays for high resolution scans of C1s 
(A), Cl2p (B), and O1s (C), and XPS survey scan overlay (D) for PES flat sheets.
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Table 3.  PES flat sheet membranes analyzed using XPS in three different areas on one flat sheet membrane. Percentages are 
determined from the peak areas of the C 1s, O 1s, and Cl 2p high resolution XPS spectra.  The element listed first indicates the 
source of the photoelectron.  * indicates a significant difference from the sodium acetate control, 4HBA control, and 3Cl4HBA 
control at the 95% confidence level using a single factor ANOVA with Bonferroni post hoc test.  ND indicates not detected 
(≤0.1). 
 
 C-C C-O-C C-S COOH O-C O-S Cl
- 
Cl
- 
C-Cl C-Cl 
Binding 
Energy 
(eV) 
284.77±0
0.093  
286.23 
±0.093  
288.81 
±0.09  
287.85 
±0.14 
531.72 
±0.19  
533.35 
±0.12  
197.92 
±0.07 
199.52 
±0.07 
200.32 
±0.04 
201.92 
±0.04 
Sodium 
Acetate 
Control 
55.32 
±3.33% 
13.89 
±0.95% 
7.79 
±0.95% 
ND 
 
12.54 
±0.96% 
10.46 
±1.07% 
ND ND ND ND 
4HBA 
Control 
57.25 
±0.78% 
11.00 
±4.26% 
7.20 
±0.79% 
ND 13.09 
±1.43% 
9.41 
±1.40% 
ND ND ND ND 
3Cl4HBA 
Control 
51.28 
±3.86% 
14.88 
±1.51% 
9.00 
±0.60% 
ND 13.77 
±1.47% 
11.40 
±1.04% 
ND ND ND ND 
Laccase 
Control 
47.00 
±5.47%* 
23.28 
±0.89%* 
8.51 
±0.57% 
ND 14.06 
±4.39%* 
7.15 
±1.32%* 
ND ND ND ND 
4HBA 
Modified 
58.66 
±5.01% 
11.77 
±1.55% 
3.53 
±1.15%* 
8.62± 
0.74%* 
14.44 
±6.89% 
3.62 
±1.40%* 
ND ND ND ND 
3Cl4HBA 
Modified 
53.02 
±4.53% 
17.69 
±2.51%* 
1.12 
±0.02%* 
5.10± 
1.63%* 
12.53 
±1.95% 
6.24 
±1.45%* 
0.14 
±0.012%* 
0.077 
±0.005%* 
3.50 
±0.71%* 
1.75 
±0.36%* 
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Table 4.  Three PES flat sheet membranes analyzed using XPS. Percentages are determined from the peak areas of the C 1s, O 
1s, and Cl 2p high resolution XPS spectra.  The element listed first indicates the source of the photoelectron.  * indicates a 
significant difference from the sodium acetate control, 4HBA control, and 3Cl4HBA control at the 95% confidence level using 
a single factor ANOVA with Bonferroni post hoc test.  ND indicates not detected (≤0.1). 
 
 C-C C-O-C C-S COOH O-C O-S Cl
- 
Cl
- 
C-Cl C-Cl 
Binding 
Energy 
(eV) 
284.77 
±0.02  
286.24 
±0.07  
288.83 
±0.10  
287.95 
±0.12 
531.69 
±0.24  
533.31 
±0.31  
197.86 
±0.01 
199.46 
±0.07 
200.35 
±0.04 
201.95 
±0.03 
Sodium 
Acetate 
Control 
51.07 
±0.90% 
15.58± 
1.36% 
8.35± 
0.71% 
ND 
 
14.43 
±2.57% 
10.56 
±2.38% 
ND ND ND ND 
4HBA 
Control 
51.00 
±4.86% 
15.49 
±0.22% 
7.99 
±1.48% 
ND 14.65 
±0.97% 
10.88 
±2.68% 
ND ND ND ND 
3Cl4HBA 
Control 
49.32 
±2.86% 
16.17 
±1.31% 
8.57 
±0.45% 
ND 15.34 
±1.73% 
10.60 
±0.45% 
ND ND ND ND 
Laccase 
Control 
46.62 
±3.76% 
20.38 
±3.60%* 
8.07± 
0.47% 
ND 17.08 
±0.43% 
7.84 
±0.38% * 
ND ND ND ND 
4HBA 
Modified 
56.63 
±2.14% 
12.06 
±2.24%* 
3.64 
±1.21%* 
6.82 
±2.19%* 
12.67 
±1.90% 
7.36 
±1.55% * 
ND ND ND ND 
3Cl4HBA 
Modified 
49.13 
±6.49% 
19.62 
±2.94%* 
0.81  
±0.45%* 
5.10 
±1.82%* 
14.68 
±4.86% 
7.06 
±4.33% * 
0.22 
±0.091%* 
0.11 
±0.044%* 
2.88 
±0.24%* 
1.44 
±0.12%* 
4
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Figure 6.  IR spectra of the PES side of the flat sheet membrane for PES, 1 day 
modification, 2 day modification, 3 day modification, 4 day modification after attachment 
of 4-hydroxybenzoic acid polymers. 
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Figure 7.  IR spectra of the PET side of flat sheet membrane for PES, 1 day modification, 2 
day modification, 3 day modification, 4 day modification after attachment of 4-
hydroxybenzoic acid polymers. 
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The ATR-FTIR spectra in Figure 6 show the presence of a hydroxyl peak from the 
conjugated carboxylic acid functional group at 3300 cm
-1
 for the PES side of the membrane.  
This peak increases in size as the modification time increase.  The polyethylene terephthalate 
(PET) side of the membrane in Figure 7 shows that it is unaffected by the 4HBA modification.  
The presence of the carboxylic acid functional group is evidence of the attachment of 4HBA 
polymers on the PES surface.  The combined results from XPS and IR confirm the attachment of 
4HBA polymers on the surface of PES flat sheets.   
Protein Adsorption Experiments 
After confirming the attachment of 4HBA onto PES flat sheets, the amount of BSA and 
lysozyme adsorbed onto the surface was measured. This was done to investigate whether the 
modification would reduce nonspecific adsorption of BSA and lysozyme.  Lysozyme was chosen 
because of its isoelectric point (pI) of 11, which makes the overall charge on the protein at pH 
7.4 positive; BSA was chosen because its pI is 4.7, which makes the overall charge on the 
protein at pH 7.4 negative.  Since the 4HBA polymer introduces a carboxylic acid functional 
group (pKa=4.54) onto the surface which is deprotonated at pH 7.4, the comparison of the 
amount of BSA and lysozyme adsorbed onto the surface can give insight into the dominate 
mechanism of protein adsorption upon addition on the 4HBA polymer.  Reduction in protein 
adsorption can occur through charge repulsion and by strengthening the water polymer 
interaction.
70
  If BSA adsorption decreases and lysozyme increases, a charge-charge interaction 
dominates.  This is due to the carboxylic acid being deprotonated at pH 7.4 so lysozyme would 
be attracted to the surface and BSA would be repelled. However, if BSA and lysozyme 
adsorption decrease then the water-polymer interaction dominates.   This is due to water being 
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more tightly bound to the surface due to the interaction with the carboxylic acid functional group 
and the water must be displaced in order for proteins to adsorb to the surface.   
Initially both BSA and lysozyme were fluorescein isothiocyanate (FITC) labeled.  After 
FITC labeling BSA and lysozyme, the membranes were placed in a solution of FITC-BSA (74 
μg/mL) or FITC-lysozyme (5.5 μg/mL).  Then the difference between a solution without the 
membrane and with the membrane was used to determine the amount of protein adsorbed onto 
the surface.  This was performed for the following reasons:  1) to determine if the modification 
with 4HBA altered the amount of protein adsorbing to the surface, and 2) investigate the 
dominate mechanism (charge attraction/repulsion, water polymer interaction) of protein 
adsorption. 
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Figure 8. BSA () and lysozyme () adsorption onto PES membranes modified with 4-
hydroxybenzoic acid (4HBA) polymers for between 1 and 24 hours compared to control 
membranes.  * indicates significant difference at the 95% confidence level compared to the 
0 hour reaction time using a single factor ANOVA with Bonferroni post hoc test.  The error 
bars represent the standard deviation in protein adsorption calculated from 3 different 
solutions containing PES membranes modified with 4HBA for different reaction times.  
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The results for FITC-lysozyme adsorption, shown in Figure 8, show an increase in the 
adsorption of FITC-lysozyme after 4HBA modification. In addition, the results for the FITC-
BSA experiment, shown in Figure 8, show an initial increase in BSA adsorption which becomes 
significant at the 4 hour of reaction time followed by a decrease in BSA adsorption after 8 hours 
of reaction time.  At a 24 hour reaction time, FITC-BSA adsorption is significantly lower 
compared to the control.  For BSA, the initial increase in protein adsorption could be due to the 
graft density of the polymer on the surface which is not sufficient enough to exclude BSA. This 
could be due to the BSA being able to go between the polymer chains, and BSA becoming 
trapped within the chains of the polymer which will lead to an increase in protein adsorption. 
Moreover, the decrease in protein adsorption observed at the 24 hour reaction time is due to the 
exclusion of BSA from becoming trapped within the polymer chains due to the increase in size 
and graft density with the longer reaction time. At increased graft density there are more 
carboxylic acid functional groups which could increase charge-charge repulsion, leading to a 
decrease in BSA adsorption.  For lysozyme, the increase in protein adsorption is possibly caused 
by the 4HBA modification’s ability to trap lysozyme because lysozyme is smaller at 14 kDa 
compared to BSA at 66.5 kDa.   Also, the increase in lysozyme adsorption could be due to the 
charge-charge interaction with the deprotonated carboxylic acid functional group.   Overall this 
experiment shows that for BSA, there is a decrease in protein adsorption with the 24 hour 
reaction time, but for lysozyme there is an overall increase in protein adsorption due to a 
combination of graft density and charge-charge interactions between the polymer and the 
protein. 
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Modification of Microdialysis Membranes with 4-Hydroxybenzoic Acid Polymers 
 Following the confirmation of the covalent attachment of 4HBA polymers onto PES flat 
sheet, the reaction was applied to PES microdialysis membranes.  The attachment of 4HBA 
polymers onto the microdialysis membranes was confirmed using XPS. Then, RR values of 
FITC-labeled dextrans of 4 kDa, and 10 kDa, were determined to analyzed the effect of the 
reaction on transport as well as the effect of nonspecific adsorption of the reactants (4HBA and 
laccase).  Finally, RR of lysozyme, CCL2, VEGF, KC/GRO, TNF-, and acidic fibroblast 
growth factor (aFGF) was determined and compared to unmodified microdialysis probes.   
XPS Characterization   
The results from XPS analysis for both control and 24 hour 4HBA modified membranes 
(Table 4) show the presence of the carboxylic acid functional group at 287.90 ± 0.17 eV with 
9.73 ± 5.94%.  There is also a decrease in the O-S functional group at 532.99 ± 0.88 eV from 
3.15 ± 0.64% to not detectable values. There is also a decrease in S2p which is only found in 
PES from 3.12 ± 1.14% to 0.85 ± 0.18%.  This confirms the attachment of 4HBA polymer onto 
to the microdialysis membrane because 4HBA is the only source of the carboxylic acid 
functional group.  Also, the decrease in O-S, and S2p, only found in PES, shows the addition of 
polymer onto the surface is sufficient to not allow the photoelectrons from O-S to escape.   
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Table 5.  XPS data from control and 24 hour 4HBA modified microdialysis membranes.  
Percentages are determined from the peak areas of the C1s, O1s, and S2p high resolution 
XPS spectra.  N=3, * indicates a significant difference from the control at the 95% 
confidence level using a single factor ANOVA with Bonferroni post hoc test.  ND indicates 
not detected (≤0.1%).   
   
  C-C/C-H C-O COOH S2p O-C O-S 
eV 
284.71 ± 
0.11  
285.98 ± 
0.30 
287.90 ± 
0.17 
168.09 ± 
0.25 
531.63 ± 
0.57 
532.99 ± 
0.88 
Control 
54.65 ± 
10.40% 
22.54 ± 
6.76% ND 
3.12 ±  
1.14% 
15.14 ± 
5.07% 
3.15 ± 
0.64%* 
4HBA 
Modified 
49.83 ± 
11.88% 
17.68 ± 
6.50% 
9.73 ± 
5.94%* 
0.85 ± 
0.18%* 
14.81 ± 
4.36% 
ND 
 
Effect of Laccase and 4-Hydroxybenzoic Acid on the Relative Recovery of FITC-4 and FITC-10 
FITC-4 and FITC-10 RR of three different microdialysis probes were analyzed to 
determine if nonspecific adsorption of laccase onto the surface would alter the transport across 
the membrane.  Results shown in Figure 9 and 10 show that FITC-4 and FITC-10, RR is not 
significantly different, indicating that laccase does not adsorb to the microdialysis membrane in a 
way that inhibits the RR of FITC-4 and FITC-10.  This indicates that laccase is not adsorbing 
onto the surface to an extent that would inhibit the transport of FITC-4 and FITC-10.   
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Figure 9.  Analysis of the effect of nonspecific adsorption of laccase on FITC-4 relative 
recovery.  Three different groups were analyzed, control probes perfused and placed in a 
solution that does not contain laccase, probes perfused with a 0.5 U/mL laccase solution, 
and probes placed in a solution containing 0.5 U/mL of laccase. These results correspond to 
3 different probes tested for RR of FITC-4 at 3 different times, with each time point 
measured in triplicate. Error bars represent ± SD from mean.    
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Figure 10.  Analysis of the effect of nonspecific adsorption of laccase on FITC-10 relative 
recovery.  Three different groups were analyzed, control probes perfused and placed in a 
solution that does not contain laccase, probes perfused with a 0.5 U/mL laccase solution, 
and probes placed in a solution containing 0.5 U/mL of laccase. These results correspond to 
3 different probes tested for RR of FITC-10 at 3 different times, with each time point 
measured in triplicate.  Error bars represent ±SD from mean.   
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FITC-4, FITC-10, FITC-20 Relative Recovery after 2 and 24 Hour Reaction Time  
Next, FITC-4, FITC-10, and FITC-20 RR was tested after modification with 4HBA and 
laccase for 2 and 24 hours.  This was performed to see if the modification would hinder the RR 
of these molecules.  The results from this experiment are shown in Figures 11-13.  For FITC-4 
(Figure 11), there is a 20% decrease in RR after modification for 2 hours and a 61% decrease for 
the 24 hour modification time.  For FITC-10 (Figure 12), the RR decreased by 40% for the 2 
hour modification and 73% for the 24 hour modification.  FITC-20 (Figure 13) showed a 40% 
decrease for the 2 hour modification time and a 76% decrease for the 24 hour modification.  For 
the 2 hour modification time, there is only a slight decrease, of 20%, in RR of FITC-4 which 
then increases to 40% for FITC-10 and FITC-20.  Moreover for the 24 hour modification, FITC-
4, FITC-10 and FITC-20 RR decrease by approximately 70%. This could indicate that the longer 
modification time leads to denser polymer formation. This leads to an increase in pore blockage 
which decreases RR.  
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Figure 11. FITC-4 relative recovery for control, 2, and 24 hour 4HBA modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.   
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Figure 12.  FITC-10 relative recovery for control, 2, and 24 hour 4HBA modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.   
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Figure 13.  FITC-20 relative recovery for control, 2, and 24 hour 4HBA modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.  
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Relative Recovery of Lysozyme 
 After observing the reduction in FITC-4, FITC-10 and FITC-20 RR by modification with 
4HBA, lysozyme was tested to investigate if the reduction of the RR would occur by comparing 
protein and dextran RR.  Lysozyme is a 14 kDa protein but is more globular in structure 
compared to dextran which is more linear.
135, 136
  Figure 14 shows that there is no significant 
reduction in lysozyme RR for the 2 hour 4HBA modified microdialysis probes, but for the 24 
hour 4HBA modified microdialysis probes the lysozyme concentration were below the detection 
limit of 25 μg/mL with a 500 μg/mL solution outside the probe.  This suggests that pore blocking 
and/or charge-charge attraction is occurring after 24 hours of modification with 4HBA and 
laccase.   
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Figure 14.  Lysozyme relative recovery for control, 2 hour, and 24 hour 4HBA modified 
microdialysis probes.  Probes were placed in a solution containing 500 μg/mL of lysozyme.  
ND indicates not detected (detection limit of 25 μg/mL), N=3. 
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Relative Recovery of CCL2, VEGF, KC/GRO, aFGF, and TNF-α 
 After measuring the RR of lysozyme, the RR of CCL2, aFGF, KC/GRO, TNF-, and 
VEGF were measured.  The reason for choosing these analytes is due to their varying molecular 
weights as well as isoelectric points shown in Table 6. The 4HBA modification introduces a 
carboxylic acid functional group, which is deprotonated at pH 7.4, onto the membrane surface.  
Different analytes may interact differently with the surface based on the charge-charge 
interactions between the protein and the membrane surface.  Also by varying molecular weight, 
recovery enhancement may be altered due to the change in size of the pores based on the 
modification time.  For these experiments, 2 hour and 24 hour 4HBA modified membranes will 
be compared with control microdialysis probes.   
 
Table 6.  Molecular weight and isoelectric point (pI) values for proteins whose relative 
recoveries were analyzed.  
 
Protein Molecular Weight (kDa) pI 
TNF-α 17.2 5.0 
aFGF 15.5 5.7 
VEGF 21 8.5 
KC/GRO 7.8 9.1 
CCL2 13.1 9.3 
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Figure 15.  Box and whiskers plot of CCL2 relative recovery of control and 2 hour 4HBA 
modified microdialysis probes.  N=6  The box represents the 25
th
-75
th
  percentiles.  The line 
through the box represent the median, whiskers represent the 5
th
 and 95
th 
percentile, and 
the □ represents the mean.  * Indicates significantly different than the control at the 95% 
confidence level (p≤ 0.05) as determined by a 2 factor ANOVA with Bonferroni post hoc 
test. 
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Figure 16.  Box and whiskers plot of CCL2 relative recovery of control and 24 hour 4HBA 
modified microdialysis probes.  N=6  Significance was compared between the control and  
24 hour 4HBA modified microdialysis probes and the control at the 95% confidence level 
as determined by a 2 factor ANOVA with Bonferroni post hoc test. 
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 For CCL2, the 2 hour modification showed a significant increase in RR between 90 and 
190 % (Figure 15).  For the 24 hour modification, CCL2 RR did not increase significantly 
overall (Figure 16).  CCL2 is a 13.1 kDa protein so it is similar in molecular weight to lysozyme 
at 11 kDa.  The lack of RR increase could be due to partial pore blockage which was observed 
with the FITC-labeled dextrans.  Also, the isoelectric point of CCL2 is 9.25 which gives the 
protein an overall positive charge. This could explain the increase in RR for the 2 hour 4HBA 
modified membranes because CCL2 could bind to the surface due to the overall negative charge 
provided by the carboxylic acid functional group added by 4HBA. However, this was not 
observed in the 24 hour modified membranes due to the partial blockage of pores due to the 
increase in size and/or graft density with a longer modification time. 
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Figure 17.  Box and whiskers plot of VEGF relative recovery of control, 2 and 24 hour 
4HBA modified microdialysis probes.  N=3  * Indicates significantly different than the 
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni 
post hoc test. 
 
A comparison of RR for VEGF between control and 4HBA modified membranes is 
shown in Figure 17.  This figure shows an increase in RR for the 2 hour 4HBA modification but 
not for the 24 hour modification.  This absence of an increase in RR for the 24 hour 4HBA 
modification could be due to the pores size becoming reduced because of the longer modification 
time.  
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Figure 18.  Box and whiskers plot of KC/GRO relative recovery of control, and 2 hour 
4HBA modified microdialysis probes.  N=3 * Indicates significantly different than the 
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni 
post hoc test. 
 
KC/GRO is a 7.8 kDa protein with an isoelectric point of 9.1.  KC/GRO relative recovery 
was analyzed because at pH 7.4 the protein has an overall positive charge.  As seen with CCL2 
and VEGF which also have isoelectric points above 7.4, the relative recovery increased upon 
modification with 4HBA for 2 hours.  In Figure 18, the relative recovery of KC/GRO was shown 
to increase by the addition of the 4HBA polymer after modification for 2 hours.  This is 
consistent with the increase in relative recovery after modification with 4HBA for 2 hours for 
proteins with isoelectric points above 7.4.   
Flush Hour 1 Hour 2 Hour 3 Hour 4
0
20
40
60
R
e
la
ti
v
e
 R
e
c
o
v
e
ry
 (
%
)
 Control
 2 Hour 4HBA Modified
KC/GRO
* 
* * * 
  
 
65 
 
Figure 19.  Box and whiskers plot of aFGF relative recovery of control, 2 and 24 hour 
4HBA modified microdialysis probes.  N=3 * Indicates significantly different than the 
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni 
post hoc test. 
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Figure 20.  Box and whiskers plot of TNF-α relative recovery of control, 2 hour 4HBA 
modified microdialysis probes.  N=3 * Indicates significantly different than the control at 
the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni post hoc 
test. 
 
For aFGF, there was a significant increase in RR at hour 4 between the control and 2 hour 
4HBA modified membranes (Figure 19).  CCL2 (13.1 kDa) is slightly smaller than aFGF (15.5 
kDa), and also aFGF has an overall negative charge based on the isoelectric point (pI 5.6). The 
charge-charge repulsion between aFGF, and 4HBA could explain the lack of RR increase. RR of 
TNF-α a 17.2 kDa protein with an isoelectric point of 5.0 was analyzed for the 2 hour 4HBA 
modification.  The RR for TNF- after 2 hour 4HBA modification, as shown in Figure 20, was 
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not significantly different than the control RR this could be due to charge-charge repulsion 
between the negatively charged surface and TNF-α which has an overall negative charge.    
For CCL2, VEGF, and KC/GRO the RR increased for the 2 hour modification.  RR did 
not increase with the 2 hour 4HBA modification for aFGF and TNF-α.  This RR increase was not 
observed for CCL2 and VEGF for the 24 hour modification time.  For aFGF the increase in RR 
was only observed at hour 4 for the 2 hour modification time.  TNF-α and aFGF have isoelectric 
points of 5.0, and 5.7 compared to CCL2, VEGF, and KC/GRO at 9.3, 8.5, and 9.1.  The 
modification adds a negative charge onto the surface by the carboxylic acid functional group.  
Being that aFGF and TNF-α have an overall negative charge there may be charge repulsion 
between the protein and the surface.  For CCL2, VEGF, and KC/GRO the overall positive charge 
may introduce charge attraction between the protein and the surface.  This could lead to the 
larger increase in RR due to the attractive force between CCL2, VEGF, and KC/GRO. 
Conclusions  
 This chapter shows successful attachment of 4HBA polymers onto flat sheet and 
microdialysis membranes using both XPS and ATR-FTIR data.  BSA adsorption onto PES flat 
sheet shows an initial increase followed by a decrease in BSA adsorption that becomes 
significant at 24 hours.  For lysozyme the adsorption increased upon addition of 4HBA polymers 
onto the surface.  RR experiments using FITC-labeled dextrans showed a decrease in RR for the 
24 hour reaction time of approximately 70% and a slight decrease for the 2 hour reaction time.  
The RR experiment for lysozyme showed no significant difference for the 2 hour modification 
time but was not detectable for the 24 hour modification time.  For CCL2, VEGF, and KC/GRO 
the 2 hour reaction time showed a two to three fold increase in RR for the 2 hour 4HBA 
modification.            
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CHAPTER 3.  COMPARISON OF PROTEIN ADSORPTION METHODS  
 
Introduction    
Many researchers are quantifying protein absorption onto surfaces to improve 
implantable devices as well as membrane purification devices. Nonspecific adsorption of 
proteins can lead to reduced recovery across the membrane surface, fouling of the device and 
inaccurate measurements.
62-64
  Protein adsorption is a commonly measured parameter to 
determine the effectiveness of their device or treatment, but many different methods are used to 
determine the amount of protein adsorbed.
137
  When making a comparison between different 
modifications to a surface, one must consider the fact that protein adsorption may be measured 
using different methods.  This can make comparing reported results from different methods 
difficult.  
Materials and Methods 
Materials 
Bovine Serum Albumin fraction V, was purchased from Rockland (Pottstown, PA) and 
was certified immunoglobulin and protease free.  Lysozyme was purchased from MP 
biomedicals (Solon, OH).  100 kDa PES flat sheet membranes (UE50) were purchased from 
Sterlitech (Kent, WA).  Fluorescein isothiocyanate isomer 1 was purchased from Alfa Aesar 
(Haverhill, MA).  Dimethyl sulfoxide was purchased from Electron Microscopy Sciences 
(Hatfield, PA).  Sodium hydroxide was purchased from Mallinckrodt Chemicals (St. Louis, 
MO).  Sodium dodecyl sulfate was purchased from J. T. Baker (Phillipsburg, NJ).  Dibasic 
sodium phosphate (ACS grade) was purchased from EMP (Howell, NJ).  Sodium chloride 
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bioXtra grade, potassium chloride (99.0%), and monobasic potassium phosphate (ACS grade) 
where purchased from Sigma Aldrich (St. Louis, MO).  
Protein Adsorption Measured by Absorbance at 280 nm and BCA Assay 
PES flat sheet membranes of approximately 25 cm
2
 were cut into pieces of approximately 
1 cm
2
 and placed in a solution containing either 0.5 mg/mL or 0.25 mg/mL of BSA or lysozyme 
in PBS (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4) pH 7.4.  The 
solution was placed on a plate shaker and samples were then collected from the solution after 2, 
24, 48 and 72 hours.  Then, an absorbance value at 280 nm was measured and samples were also 
analyzed using a standard BCA assay.
130
     
Protein Adsorption Measured by Removal with SDS and 0.05 M Sodium Hydroxide 
PES flat sheet membranes of approximately 5 cm
2
 were cut into pieces of approximately 
1 cm
2
 and placed in a solution containing 4.5 mg/mL of either BSA or lysozyme in PBS pH 7.4.   
The solution was placed on a plate shaker and the membranes were removed from the solution 
after 2, 24, 48 and 72 hours and placed in a solution containing 2 wt % SDS and 0.05 M NaOH 
for 2 hours.
87
  An aliquot was then removed and an absorbance value at 280 nm was measured.  
This value was then compared to a calibration curve of known BSA and lysozyme concentrations 
in 2 wt% SDS and 0.05 M NaOH.       
Protein Adsorption Measured using FITC-labeled Proteins 
FITC-Labeling BSA and Lysozyme  
FITC-labeling of both BSA and lysozyme was performed by placing 1 mg of FITC into 
10 μL of DMSO, and dissolving 10 mg of BSA or lysozyme into 990 μL of 0.1 M phosphate at 
pH 8.0.  These two solutions were then combined and incubated at 37°C for 2 hours.  The 
solution was then filtered using a NAP-25 Sephedex G-25 column to separate the FITC-labeled 
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protein and the free FITC.  The concentration of FITC labeled protein was determined based on 
the absorbance at 280 nm.   
Protein Adsorption Measurements 
For the FITC-BSA adsorption experiment PES flat sheet membranes were placed in a 
solution containing 74 μg/mL of FITC-BSA in PBS pH 7.4 and allowed to incubate for 2, 24, 48 
or 72 hours.  Then, the solution was removed and the fluorescence intensity measured using an 
excitation wavelength was 485 nm and the emission was measured from 500-650 nm.  The 
emission maxima for FITC-BSA after incubation with the PES membranes were between 517 
nm and 520 nm.  For FITC-lysozyme, the membranes were placed in a solution containing 5.5 
μg/mL of FITC-lysozyme in PBS pH 7.4.  The emission maxima were between 515 nm and 517 
nm for FITC-lysozyme after incubation with the membrane.  To determine the concentration a 
calibration curve was made for both FITC-BSA and FITC-lysozyme from the stock solutions 
above.  The concentration in μg/mL was then converted to μg/cm2 based on the sum of the 
surface areas of the membrane pieces and the volume of the solution.      
Results and Discussion 
Protein Adsorption Measured by Absorbance at 280 nm and BCA Assay 
 Initially an experiment was performed using a surface areas differing by tenfold 
(approximately 1 cm
2
 and 10 cm
2
).  The difference in concentration between the solution with 
the membrane and without the membrane was non-detectable for both the 280 nm, and BCA 
assay detection methods using incubation times of 2, 24, and 48 hours.  To combat the issue of 
not being able to detect the difference in concentration between the solution with the membrane 
and without the membrane, the total surface area was increased to approximately 25 cm
2
.  Two 
aliquots of the solution (with and without membranes) were used for the BCA and absorbance at 
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280 nm detection methods.  The membranes were also incubated in a solution containing either 
0.5 mg/mL or 0.25 mg/mL of BSA or lysozyme.  A comparison between the two methods is 
shown in Table 7 and 8 for BSA and lysozyme.  
Table 7.  Comparison of BCA and 280 nm for BSA (0.50 mg/mL, 0.25 mg/mL).  Symbol 
indicates significantly different at the 95% confidence level as compared to ND(*) and 24 
hour time point (#). 
 
Detection 
Method 
Concentration 2 hours 
(μg/cm2) 
24 hours 
(μg/cm2) 
48 hours 
(μg/cm2) 
72 hours 
(μg/cm2) 
Absorbance 
at 280 nm 
0.50 mg/mL ND 22.88±11.90* 43.96±21.97* ND 
0.25 mg/mL ND 16.44±3.38* 40.22±4.51*# 32.35±1.66*# 
BCA 0.50 mg/mL ND ND 4.49 ±1.69* 3.80±1.95* 
0.25 mg/mL ND ND ND 3.32±1.48* 
 
 
For BSA protein adsorption measured using the detection method of absorbance at 280 
nm; there was no significant difference between amount of protein adsorbed per unit surface area 
for the 24 hour and 48 hour incubation time.  There was also no significant difference at the 72 
hour incubation time for the BCA detection method.  For the 72 hour incubation time, the 
amount of protein adsorbed measured by the absorbance change at 280 nm was non-detectable 
for the BSA concentration of 0.5 mg/mL, but it was detectable for the 0.25 mg/mL 
concentration.  For the BCA detection method the amount of protein adsorbed onto the surface 
was detectable for the 0.5 mg/mL BSA concentration but non-detectable for the 0.25 mg/mL 
BSA concentration.  The 2 hour incubation showed non-detectable amounts of protein adsorbed 
for both the absorbance at 280 nm and BCA detection methods.  The 24 hour incubation time 
also showed a non-detectable amount of protein adsorbed using the BCA method but showed 
detectable amounts using the absorbance at 280 nm.  Between the absorbance at 280 nm and 
BCA detection methods at the 48 hour incubation time using the 0.50 mg/mL concentration of 
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BSA was not significantly different.  At the 72 hour incubation time the methods were compared 
using the 0.25 mg/mL concentration and showed a significant difference between the two 
methods.  As can be seen in Table 7 incubation time affects protein adsorption measurements as 
well as the concentration of the protein used.  Also, protein adsorption calculated using the 
absorbance at 280 nm is significantly larger than that calculated from the same solution using the 
BCA method.  This could be due to these methods measuring different properties of the 
molecules and possible interference in measuring the absorbance at 280 nm.  The difference 
method using the absorbance at 280 nm uses the intrinsic absorbance from aromatic amino acids 
present in the protein, mostly tyrosine and tryptophan.
129
  The BCA assay is a colorimetric assay 
that uses the reduction of Cu
2+
 to Cu
1+
 by proteins in an alkaline medium with detection of the 
Cu
1+
 by bicinchoninic acid.
130
          
Table 8.  Comparison of BCA and 280 nm for Lysozyme (0.50 mg/mL, 0.25 mg/mL). * 
indicates difference as compared to ND. 
 
Detection 
Method 
Concentration 2 hours 
(μg/cm2) 
24 hours 
(μg/cm2) 
48 hours 
(μg/cm2) 
72 hours 
(μg/cm2) 
Absorbance 
at 280 nm 
0.5 mg/mL ND ND 16.60±6.21* 12.39±3.23* 
0.25 mg/mL ND 5.13±3.50* 18.94±2.45* 16.84±12.46* 
BCA 0.5 mg/mL ND ND ND 9.23±4.51* 
0.25 mg/mL ND 3.33±1.50* 4.99±2.56* 4.90±1.45* 
 
For lysozyme (Table 8), there is no significant difference between the 48 hour and 72 
hour incubation period for absorbance at 280 nm and for 72 hours BCA detection method.  Since 
there was no significant difference between the concentrations of lysozyme for the BCA and 
absorbance 280 nm detection methods individually, the data was pooled to compare the protein 
adsorbed using the two detection methods.  There was found to be no significant difference 
between the BCA and 280 nm detection methods at the 72 hour time point; data was pooled for 
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the comparison of methods.  For 24 hour and 48 hour time points, the data for the 0.25 mg/mL 
concentration was used for comparison and showed no significant difference in the methods for 
the 24 hour incubation time, but at the 48 hour incubation time the difference is significant.  For 
lysozyme for the absorbance at 280 nm and BCA assay 72 hours of incubation in necessary to 
detect protein adsorption.  Lysozyme protein adsorption determined using the BCA and 
absorbance at 280 nm detection method also showed different protein adsorption values for 
different incubation times as well as different concentrations.  This again could be due to the 
different properties of the molecule and possible interference using the absorbance at 280 nm.        
Comparison of Protein Adsorption Methods using Detection Methods of Absorbance at 280 
nm, BCA Assay, FITC-Labeled Proteins, and a Removal Method using SDS and NaOH 
 To compare with the removal method using SDS and NaOH, and FITC-labeling, the 0.25 
mg/mL protein concentration was used for the BCA and absorbance at 280 nm detection 
methods.  Table 9 shows the comparison of the different methods using BSA. For the BCA assay 
detection method the protein adsorption, is non-detectable until 72 hours of incubation with the 
protein solution.  Table 10 shows a comparison of different detection methods for lysozyme.  
The amount of protein adsorbed was non-detectable for the 2 hour incubation time for the 
absorbance at 280 nm and BCA detection methods.   
 A comparison between the different detection methods for each incubation was 
performed.  For the 2 hour incubation time, the BCA and absorbance at 280 nm methods showed 
non-detectable amount of BSA adsorbed on the surface.  For the 24 hour incubation time, the 
removal method with SDS and NaOH showed significantly different protein adsorption than the 
other three methods (absorbance at 280 nm, BCA, and FITC-BSA) and also the BCA detection 
method showed non-detectable concentration of BSA adsorption.  For the 48 hour incubation 
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time, the FITC-BSA method was significantly different compared to the absorbance at 280 nm 
and removal method with SDS and NaOH. Also, the removal method with SDS and NaOH was 
significantly different than the absorbance at 280 nm detection method.  For the 72 hour 
incubation period, the removal method with SDS and NaOH was significantly different than the 
other three detection methods; the absorbance at 280 nm was significantly different than the 
BCA, and FITC-BSA detection methods.   
 Next a comparison was made for each method within each incubation time.  For the 
removal method with SDS and NaOH, the 2 hour incubation time was significantly different than 
the other three incubation times.  The absorbance at 280 nm detection method showed a 
significant difference between the 24 hour incubation time and the 48 and 72 hour incubation 
times.  At the 2 hour incubation time, protein adsorption was non-detectable for the absorbance 
at 280 nm detection method.  For the BCA assay detection method, the 72 hour incubation was 
the only incubation time to show detectable protein adsorption.  The FITC-BSA detection 
method showed a significant difference between the 2 hour and 24 hour incubation time, the 24 
hour and 48 hour incubation time, and the 72 hour incubation time with the 2, 24, and 48 hour 
incubation times.   
For lysozyme a comparison was made between each detection method within each 
incubation time.  For the 2 hour incubation time, the removal method with SDS and NaOH and 
FITC-lysozyme were significantly different, and for the absorbance at 280 nm and BCA assay 
showed non-detectable values of protein adsorbed onto the surface.   
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Table 9.  Comparison of methods to measure BSA adsorption at various time points using 
the protein adsorption methods by difference using detection methods of absorbance at 280 
nm, BCA assay, and FITC-labeled BSA methods and removal method using SDS and 
NaOH.  SDS (*) 280 nm (#), BCA (^), and FITC-BSA(~)indicates significantly different at 
the 95% confidence level compared to detection listed next to symbol.  ND=not detected. 
 
Method 2 hours 
(μg/cm2) 
24 hours 
(μg/cm2) 
48 hours 
(μg/cm2) 
72 hours 
(μg/cm2) 
SDS/NaOH 12.27±2.83~ 89.07±26.46#~ 69.07±2.21~ 73.01±15.05#^~ 
280 nm ND 16.44±3.38* 40.22±4.51*~ 32.35±1.66*^ 
BCA Assay ND ND ND 3.32±1.48*# 
FITC-BSA 5.70±0.41* 7.90±0.14* 6.74±0.66* 9.15±0.10*# 
 
Table 10.  Comparison of methods to measure lysozyme adsorption at various time points 
using the protein adsorption methods by difference using detection methods of absorbance 
at 280 nm, BCA assay, and FITC-labeled BSA methods and removal method using SDS 
and NaOH.  SDS (*) 280 nm (#), BCA (^), and FITC-lysozyme(~) indicates significantly 
different at the 95% confidence level compared to detection listed next to symbol.  ND=not 
detected. 
 
Method 2 hours  
(μg/cm2) 
24 hours 
(μg/cm2) 
48 hours 
(μg/cm2) 
72 hours 
(μg/cm2) 
SDS/NaOH 34.05±6.43~ 15.25±5.20#^~ 17.70±2.73^~ 20.59±4.00~ 
280 nm ND 5.13±3.50* 18.94±2.45^~ 16.84±12.46 
BCA Assay ND 3.33±1.50* 4.99±2.56*# 4.90±1.45 
FITC-Lys 0.33±0.35* 0.61±0.14* 0.36±0.10*# 0.72±0.13* 
 
Then, for the 24 hour incubation time there was a significant difference between the SDS and 
NaOH removal method compared to the other three detection methods (BCA assay, absorbance 
at 280 nm, and FITC-lysozyme).  For the 48 hour incubation time, the absorbance at 280 nm was 
significantly different than the BCA assay and FITC-lysozyme detection methods, and the 
removal method with SDS and NaOH was significantly different than the BCA assay and FITC-
lysozyme detection methods.  The 72 hour incubation time showed a significant difference 
between the removal method with SDS and NaOH and FITC-lysozyme.   
Next a comparison was made between incubation time for each method.  For the 
absorbance at 280 nm and the BCA detection methods the 2 hour incubation time was 
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significantly different than the 24, 48 and 72 hour incubation time.  Then, for FITC-lysozyme, 2 
hour and 72 hour incubation times were significantly different; for the removal method with SDS 
and NaOH the 2 hour incubation time and the 24 and 48 hour incubation times were significantly 
different.   
The absorbance at 280 nm and removal with NaOH and SDS showed significantly higher 
protein adsorption than the BCA and FITC-labeled protein detection methods.  This could be due 
to the SDS/NaOH removal method using the absorbance at 280 nm as the detection method to 
quantify protein adsorption.  The absorbance at 280 nm could have interference from other 
molecules in the solution.  The FITC-labeled protein and removal method with NaOH and SDS 
showed detectable protein adsorption values for all incubation times.  Being that the removal 
method with SDS and NaOH is dependent on the interactions between the surface and the 
protein the removal with SDS and NaOH may become more or less effective.  This can become 
an issue when comparing a modified surface to an unmodified surface especially if the 
modification is reducing nonspecific adsorption.  This can falsely lead to an increase in protein 
adsorption when actually the removal was more effective for one surface compared to another. 
Conclusions 
When comparing protein adsorption values reported in the literature, it is necessary to 
consider what methods they used to determine protein adsorption.  Different methods, even 
when analyzing the same sample, can give significantly different protein adsorption values this is 
shown, in Table 7 and 8, that the BCA method and the absorbance at 280 nm method for 
lysozyme and BSA.  Incubation time and detection methods can also be a factor in comparing 
protein adsorption values.   
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CHAPTER 4.  CHARACTERIZATION OF LACCASE REACTION WITH 4-
HYDROXYBENZOIC ACID 
 
Introduction 
Determination of the structure and molecular weight distribution of the polymer that is 
added to the PES membrane surface is important to understanding the protein adsorption 
properties of the polymer.   Understanding of the structure of the polymer such as the structure of 
the chains in terms of branching, the size, and molecular weight distribution can give insight 
about the transport across the membrane. Others have reported using gel permeation 
chromatography the number average molecular weight (Mn) of 8,500 Da and a weight average 
molecular weight (Mw) of 17,550 Da for a 4 hour reaction time on the reaction of 4HBA with 
laccase, Trametes villosa.  This is a different species than the Trametes versicolor enzyme that is 
used in this dissertation.
93
  The polymerization reaction between laccase from Trametes 
versicolor, 3-chloro-4-hydroxybenzic acid (3Cl4HBA) and 4HBA were characterized to 
determine the distributions of molecular weights present at different polymerization times.  This 
information provides insight into the modification that is occurring on the PES membrane 
surface.   
Materials and Methods 
Materials  
 Laccase form Trametes versicolor, sodium acetate, fluorescein isothiocyanate dextran 
4,000, and methyl orange were purchased from Sigma Aldrich (St. Louis, MO), 4-
hydroxybenzoic acid was purchased from TCI (Portland, OR).  3-chloro-4-hydroxybenzoic acid, 
and 2-5-dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill, MA).  HPLC grade 
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methanol and water were purchased from Fisher Scientific (Waltham, MA).  Glacial acetic acid 
was purchased from VWR international (Radnor, PA).  NAP-25 Sephedex G-25 column were 
purchased from GE healthcare (Chicago, IL).  Amicon Ultra centrifugal filters of 3, 10, and 50 
kDa molecular weight cut-off were purchased from EMD Millipore (Billerica, MA). 
HPLC-UV Experiment to Separate Monomer from Polymer 
An initial experiment was performed to see if using high performance liquid 
chromatography (HPLC) with an ultraviolet (UV) detector, the monomer (4HBA or 3Cl4HBA) 
could be separated from any formed polymer.  First the reaction of 28.8 mM 3Cl4HBA and 
4HBA in the presence of 0.5 U/mL of laccase in sodium acetate buffer pH 5.0 was allowed to 
react for 1 and 2 hours.  After the specified reaction time, 2 mL of the 10 mL total sample was 
then centrifuged using a bench top centrifuge for 2 minutes.  The precipitate was then collected 
and dissolved in 500 μL of 75% methanol/25% water and half of this sample was then filtered 
through a 0.2 μm syringe filter.  Then, the samples were analyzed using the HPLC-UV using a 
C18 5 μm column, solvent of 65% methanol/35% water at a flow rate on 1 mL/min for 20 
minutes, at a wavelength of 254 nm. 
MALDI-TOF  
 To further analyze the polymer a polymerization solution with 0.5 U/mL of laccase and 
28.8 mM 4HBA in sodium acetate pH 5 in a total volume of 2 mL was made.  Then, a 90 μL 
aliquot of the solution was added every 15 minutes to a conical tube containing 10 μL of 10% 
acetic acid to reduce the pH to 2 and halt the reaction for a total of 3 hours.  The samples were 
then filtered through a 10 kDa molecular weight cut-off centrifugal filter to remove the laccase 
enzyme.  Each sample was then diluted by 50% with 1 M 2,5-dihydroxybenzoic acid in water 
and then spotted on a MALDI plate in triplicate.   
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Separation of Polymer from Monomer using Molecular Weight Cut-Off Filters and 
Analyzing the Effluent using HPLC 
To determine the molecular weight of the polymer, a separation technique was performed 
using centrifugal filters with Amicon Ultra 3, 10 and 50 kDa molecular weight cut-off.  This was 
in order to see if the polymer would be excluded by one of these MWCO filters and to give an 
approximate molecular weight range of the synthesized polymer.  The filtrate collected was then 
analyzed on the HPLC-UV.  A modification solution containing 28.8 mM 4HBA and 0.5 U/mL 
of laccase was allowed to react for 24 hours.  Then, 500 μL samples were collected and placed in 
either a 3, 10 or 50 kDa MWCO centrifugal filter and centrifuged at 14,000 x g for 30 minutes.  
The filter was then inverted and placed in a new microcentrifuge tube which was centrifuged at 
1,000 x g for 2 minutes.  The samples where then diluted 1 to 100 in 50% methanol/water and 
were injected onto the HPLC-UV with a mobile phase of 50% acetonitrile/water and a flow rate 
of 1 mL/min.   
Gel Permeation Chromatography (GPC) Separation of 4HBA Polymer Solution 
GPC was performed to gain a better understanding of the molecular weight distribution 
of the polymer present.  This experiment was performed on a reaction mixture that was allowed 
to react for 3 days.  The 4HBA precipitate solution was made by taking 2 mL of the 
polymerization solution and centrifuging for 8 minutes at 13,500 rpm.  The solution was 
decanted and the precipitate was reconstituted in 500 μL of sodium acetate pH 5.0 for each 1 mL 
aliquot, and then the two aliquots were combined.  Then the NAP-25 Sephedex G-25 column 
(exclusion limit of 5,000 Da) was conditioned with 4 mL of 0.1 M sodium acetate pH 5.0 and 
either 1 mL of the 4HBA polymer solution or the reconstituted precipitate was loaded onto the 
column.  Then, 0.1 M sodium acetate pH 5.0 was added to the column to continue the flow and 
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samples were collected in 1 minute intervals, equaling a sample volume of approximately 1.5 mL 
per minute, for a total of 21 minutes for the 4HBA precipitate solution and for 15 minutes for the 
4HBA polymerization solution.  
HPLC-UV Analysis of GPC Effluent 
After performing GPC above the experiment was repeated and samples were collected 
every 15 seconds using the method described above.  Samples 4 (4.25 minutes), 5 (4.5 minutes), 
14 (7.25 minutes), 15 (7.5 minutes), and 16 (7.75 minutes) at the apex of the two peaks were 
selected for HPLC-UV analysis.  Each sample was diluted 1 to 10 with acetonitrile.  Then, 20 μL 
samples were in injected onto the column with a mobile phase of 50/50 acetonitrile/water at a 
flow rate of 1.5 mL/min.  The UV detector was set at 254 nm using a Restek Ultra C18 5 μm 
column.    
Calibration of GPC with Methyl Orange and FITC-4 
 This experiment was performed using the reaction mixture of 28.8 mM 4HBA with 0.5 
U/mL of laccase from Trametes versicolor after 24 hours.  After the NAP-25 Sephedex G-25 
column was conditioned with 4 mL of 0.1 M sodium acetate pH 5.0, 1 mL of the 4HBA polymer 
solution was loaded onto the column.  Then, 0.1 M sodium acetate pH 5.0 was loaded onto the 
column, and samples were collected in 30 second intervals for a total of 25 minutes.  Then, the 
absorbance values of the samples were measured at 280 nm and 250 nm.  Next solutions of 
fluorescein isothiocyanate (FITC-4) (4,389 Da) and methyl orange (327 Da) were loaded onto 
the column, and samples were collected using the procedure described above. The absorbance 
measurements were made at 460 nm and 494 nm for methyl orange and FITC-4 solutions.   
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GPC of 4-Hydroxybenzoic Acid Solution 
The purpose of this experiment was to determine the molecular weight distribution of the 
4HBA polymer formed in solution.  This was done using a GPC column with an exclusion limit 
of 5,000 Da.  This experiment was performed using the reaction mixture of 28.8 mM 4HBA with 
0.5 U/mL of laccase from Trametes versicolor after 2 and 24 hours.  After the NAP-25, 
Sephedex G-25 column was condition with 4 mL of 0.1 M sodium acetate pH 5.0, 1 mL of the 
4HBA polymer solution was loaded onto the column.  Then, 0.1 M sodium acetate pH 5.0 was 
loaded onto the column, and samples were collected in 30 second intervals for a total of 12.5 
minutes.  The absorbance values of the samples were measured at 280 nm and 250 nm.  Also, a 
solution of 0.6 mg/mL of 4HBA (monomer) was analyzed.   
Direct Infusion-Mass Spectrometry Methods 
Three groups of samples were prepared, one with a buffer of 0.1 M sodium acetate pH 
5.0, one with 0.1 M ammonium acetate pH 5.0, and one prepared with water.  Also 28.8 mM 
4HBA was made in each one of the solvents and another with 28.8 mM 4HBA and 0.5 U/mL 
laccase.  First, the 4HBA and the 4HBA with laccase solutions, and a solution containing the 
solvent (blank) were passed through a NAP-25 column with the corresponding solvent and 
samples were collected from minute 5 to minute 10.  The samples were then diluted 1,000 fold 
with HPLC grade water.  These samples were then analyzed using direct infusion at a flow rate 
of 0.05 mL/min into an electrospray quadrupole ion trap mass spectrometer with a solvent of 
methanol with 0.1% formic acid.   
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Results and Discussion 
HPLC-UV Experiment to Separate Monomer from Polymer 
To detect polymer formation an experiment was designed to analyze the monomer and 
the polymerization solution after 1 and 2 hour reaction times.  The samples collected were 
centrifuged and precipitate collected.  The precipitate was then diluted in the mobile phase (75% 
methanol/water) was filtered through a 0.2 μm filter.  Both of these samples were then analyzed 
on the HPLC-UV.  In Figure 21, the results for the reaction with 4HBA are shown, and in Figure 
21 the results for the reaction with 3Cl4HBA are shown.   Both reaction mixtures show the 
presence of an initial peak at approximately 2.5 to 3 minutes which contains the monomer and 
possibly polymers that retain on the column similar to the monomer.  This is confirmed by the 
retention time being similar to the monomer (4HBA, 3Cl4HBA) shown below.  The next peak at 
approximately 8 minutes for the 1 hour reaction and 11 minutes for the 2 hour reaction is the 
polymer.  Further analysis on these peaks was performed to confirm the identity of the first peak 
as the monomer and identify the molecular weight of the polymer using MALDI-TOF.   
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Figure 21.  HPLC results for 4-hydroxybenzoic acid with laccase for a 1 and 2 hour 
reaction times as well as a solution of 4-hydroxybenzoic acid (0.288 mM 4HBA).   
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Figure 22.  HPLC results for 3-chloro-4-hydroxybenzoic acid with laccase for 1 and 2 hour 
reaction times, and a solution of 3-chloro-4-hydroxybenzoic acid (0.288 mM 3Cl4HBA). 
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MALDI-TOF to Determine Polymer Characteristics 
Analysis on the 4HBA modification solution and the precipitate formed in the 
polymerization reaction was analyzed using MALDI-TOF mass spectrometry to determine the 
molecular weight of the polymer.  Being that the monomer (4HBA) is very similar in structure to 
the matrix 2,5-dihydroxybenzoic acid, the 4HBA was not distinguishable from the multimers 
formed from the matrix.  This also made it difficult to determine what was 4HBA polymer as 
well.     
Separation of Polymer from Monomer using Molecular Weight Cut-Off Filters and 
Analyzing the Effluent using HPLC 
 Next an experiment was designed to separate the polymer from the monomer using 3, 10, 
and 50 kDa molecular weight centrifuge filters; based on the presence of the polymer one could 
determine a molecular weight range of the polymer.  The results from this experiment, in Figure 
23, show no significant change in the retention time; although, the intensity increased with 
increasing molecular weight cut-off.  This could indicate that more of the polymer is allowed 
through the 50 kDa filter than the 10 and 3 kDa filters, showing that some of the polymer is 
being excluded by the filter; although, not all of the polymer is excluded.   
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Figure 23.  HPLC results for 4HBA polymerization solution concentrate solutions collected 
from 3, 10, and 50 kDa molecular weight centrifugal filters.  The inset is the HPLC 
chromatogram from 1 to 3.5 minutes.   
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Gel Permeation Chromatography (GPC) Separation of 4HBA Modification Solution 
 To further characterize the size distribution of the polymer formed when 4HBA reacts 
with laccase; the reaction mixture was passed through a gel permeation chromatography (GPC) 
column.  GPC is a technique that separates molecules based on their size, as compared to 
reversed phase HPLC with a C18 column which separates molecules by their polarity.   With 
proper calibration, this method can be used to determine the number average and weight average 
molecular weights as well as the polydispersity.  The purpose of this experiment was to separate 
the polymer formed from the monomer.  Two different samples were analyzed using at NAP-25 
Sephedex G-25 GPC column: 4HBA polymer solution (Figure 24) and the reconstituted 
precipitate (Figure 25).   
The conclusions from this experiment are that for the polymerization solutions (Figure 
24) there are 2 regions of polymer of different molecular weight which can be seen by the two 
peaks at the 250 nm wavelength.  Also, there is a peak shown by the absorbance at 280 nm that 
elutes between these 2 peaks at 250 nm.  The NAP-25 column has an exclusion limit of 5 kDa.  
Considering the enzyme is 55 kDa; the enzyme itself is more than likely not eluting at minute 6. 
This peak could possibly be polymer forming that absorbs at 280 nm.  For the reconstitute 
precipitate (Figure 25), there is only one peak present between minute 4 and minute 9 at 250 nm 
as compared to the 4HBA polymerization solution that has 2 peaks present in that time frame.  
This difference could be due to the decrease in the intensity of the peak for the precipitate sample 
or an increase in the species that is eluting at the 7 minute time point.   
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Figure 24.  Absorbance values for aliquots collected every minute for 15 minutes from a 
NAP-25, Sephedex G-25 column loaded with 1 mL of the polymerization solution.  
Absorbance at 280 nm and 250 nm were measured.      
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Figure 25.  Absorbance values for aliquots collected every minute for 21 minutes from a 
NAP-25, Sephedex G-25 column loaded with 1 mL of the reconstituted precipitate.    
 
To further analyze the fractions collected with GPC, HPLC analysis was performed.  This 
was in order to see if the initial peak for 4HBA decreased and the suspected polymer peak 
increased with increasing elution time on the GPC column.  
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Table 11.  HPLC-UV analysis of GPC fractions showing retention time and peak area at an 
absorbance value of 254 nm.  
  
Fraction (time) 
Peak 1 Peak 2 
Retention Time 
(minutes) 
Peak Area Retention Time 
(minutes) 
Peak Area 
4 (4.25 minutes) 0.406  2,138,076 1.382 61,846 
5 (4.5 minutes) 0.408  4,022,054 1.398 42,172 
14 (7.25 minutes) 0.432 3,136,303 1.407 52,218 
15 (7.5 minutes) 0.421  2,239,927 1.397 82,700 
16 (7.75 minutes) 0.417 1,578,258 1.398 80,093 
 
The results from this experiment (Table 11) show the presence of a peak at approximately 
0.4 minutes and a smaller peak at approximately 1.4 minutes.  Considering that samples 4-5 and 
14-16 were from two different regions in the GPC experiment shown in Figure 24, but eluted at 
the same time for the HPLC experiment, indicates that the two sets of polymers are of very 
similar chemical structure but are different in size.  For the initial peak, there is an initial increase 
in the area followed by a decrease in area after fraction 5.  This indicates that there is more 
monomer and/or small polymer in the initial samples.  For the second peak the area for the later 
fractions (15, 16) is larger than the initial samples (4, 5) this indicates that there an increase in 
larger polymer in the later samples than the initial samples.  This could be an indication that the 
polymer is not following size exclusion behavior because larger polymer should elute (in earlier 
fractions) before smaller polymer.  In this experiment, the opposite is observed because the 
smaller polymer elutes in earlier fractions than does the larger polymer.  This could be due to the 
branched nature of the polymer becoming trapped in the column material leading to a longer 
retention time.     
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Calibration of GPC with Methyl Orange and FITC-4  
The experiment was then repeated with a 24 hour polymerization reaction with methyl 
orange and FITC-4 used to calibrate the GPC column.  The results from this experiment are 
shown in Figure 26.  The conclusion from this experiment is that the 24 hour polymerization 
solution has a similar GPC elution profile to the 3 day polymerization solution.  Also from this 
experiment, the polymers formed in solution are between the molecular weights of 4,389 Da 
(FITC-4) and 327 Da (methyl orange).   
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Figure 26.  Gel permeation chromatography experiment performed using a NAP-25 
Sephadex G-25 column (exclusion limit of 5 kDa) for 24 hour 4HBA polymer solution, 
methyl orange solution, and FITC-4 solution.   
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GPC of 4-Hydroxybenzoic Acid Solution 
In this experiment the monomer (4HBA) and laccase solutions were loaded onto the 
column to look at their elution behavior compared to the polymer.  As shown in Figure 27 and 28 
the laccase solution is not of sufficient concentration to absorb at 280 nm and shows no 
observable peaks that would interfere with the peaks observed for the monomer (4HBA) or the 
polymer.  Also the monomer elutes as the first peak which shows that the 4HBA polymers do not 
follow size exclusion behavior because the smaller species, the monomer, elutes first.  This 
information makes it difficult to predict the molecular weight of the polymer using this method.  
Typically for SEC the larger molecules elute first followed by the smaller molecules.  This could 
be due to the  highly branched nature of this polymer which can lead to abnormal SEC elution 
behavior due to large molecules spending too much time diffusing in and out of the column 
packing creating an Argentinean bolas effect (entanglement of a part of the macromolecule in the 
column packing) and sieving in the voids between packing spheres.
114
  In order to further 
understand the molecular weights present in the solution samples were analyzed using direct 
infusion-MS.   
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Figure 27.  Gel permeation chromatography experiment performed using a Sephadex G-25 
column (exclusion limit of 5 kDa) for 2 and 24 hour 4HBA polymer solution reaction times 
4-hydroxybenzoic acid, and laccase at 250 nm. 
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Figure 28.  Gel permeation chromatography experiment performed using a Sephadex G-25 
column (exclusion limit of 5 kDa) for 2 and 24 hour 4HBA polymer solution reaction times, 
4-hydroxybenzoic acid, and laccase at 280 nm. 
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Direct Infusion-Mass Spectrometry Experiment 
 For the direct infusion mass spectrometry experiments, three different sample solutions 
were used: water, 0.1 M sodium acetate buffer pH 5.0 and 0.1 M ammonium acetate buffer pH 
5.0.  Sodium acetate and ammonium acetate at pH 5.0 were chosen due to the conditions 
required for the polymerization reaction to occur and water was chosen to eliminate the salt 
interference for the monomer solution even though the polymerization reaction does not occur in 
water.  These solutions were then passed through the GPC column and analyze in the mass 
spectrometer.  The results from this experiment were inconclusive due to high background noise 
from the blank samples shown in Figure 29 (A), 30 (A), and 31 (A).  For the solutions containing 
4HBA (Figure 29 (B, C), 30 (B, C), and 31 (B, C)) a peak corresponding to phenol (m/z 92.6) 
could be observed.  This is from the decarboxylation of 4HBA in the ESI source.  The 
ammonium acetate buffer shows the least background.  Polymer formation could not be detected 
in the 4HBA and laccase solutions as there were no peaks present in significant quantity that 
were not present in the background or the 4HBA solution.  This could be due to polymerization 
of the monomer in the ESI ionization source.
138
  Also for the polymerization solution the 
formation of a large amount of small concentrations of a heterogeneous mixture of polymers 
could be a reason for not detecting the polymer formation using mass spectrometry.   
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Figure 29.  Mass spectra using direct infusion of fractions collected from GPC column 
containing (A) sodium acetate pH 5, (B) 4HBA in sodium acetate pH 5.0, and (C) 4HBA, 
and laccase in sodium acetate pH 5.0.   
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Figure 30.  Mass spectra using direct infusion of fractions collected from GPC column 
containing (A) water, (B) 4HBA in water, and (C) 4HBA, and laccase in water.   
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Figure 31.  Mass spectra using direct infusion of fractions collected from GPC column 
containing (A) ammonium acetate pH 5.0, (B) 4HBA in ammonium acetate pH 5.0, and (C) 
4HBA, and laccase in ammonium acetate pH 5.0.   
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Conclusions 
 From the GPC experiment the monomer and the polymer were able to be observed using 
UV absorbance at 250 nm and 280 nm.  It could also be concluded that the 4HBA monomer and 
polymer does not follow size exclusion behavior in that the monomer elutes before the polymer.  
Further analysis needs to be performed in order to understand the polymer’s distribution.  
Laccase Trametes versicolor, might require a size exclusion column which was used with 
laccase, Trametes villosa.
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CHAPTER 5.  MODIFICATION OF PES FLAT SHEETS AND MICRODIALYSIS 
MEMBRANES WITH HEPARIN TO IMPROVE RELATIVE RECOVERY  
 
Introduction 
 Microdialysis is a frequently used sampling technique to collect analytes from the 
extracellular fluid space within an organism.  Researchers are interested in the proteins found in 
the extracellular fluid space but one of the challenges to analyzing proteins is their low 
concentration and their low RR which makes them difficult to detect.  One method that has been 
previously used to increase the RR is to add a capture agent for the protein of interest into the 
perfusion fluid.  Heparin is an affinity agent that is known to bind a wide variety of proteins, 
including growth factors such as aFGF, VEGF and TGF-β.44  Heparin is also known to bind to 
IL-8, CCL2, MIP-1, RANTES and TNF-α with nM affinity.45-48  This chapter focuses on the 
characterization of the heparin modification on PES flat sheets and hollow fibers using the 
following reaction scheme (Figure 32), as well as the RR of three heparin binding proteins.   
 
Figure 32.  Reaction scheme for attachment of heparin onto PES membrane surface.   
Laccase 
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EDC/NHS 
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Materials and Methods  
Materials 
Laccase form Trametes versicolor, sodium acetate, heparin sodium salt from porcine 
intestinal mucosa, fluorescein isothiocyanate dextran 4,000, fluorescein isothiocyanate dextran 
10,000, ethylenediamine dihydrochloride and methyl orange were purchased from Sigma Aldrich 
(St. Louis, MO); 4-hydroxybenzoic acid was purchased from TCI (Portland, OR).  3-chloro-4-
hydroxybenzoic acid and 2-5-dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill, 
MA).  Sulfo-NHS premium grade, and HPLC grade methanol and water were purchased from 
Fisher Scientific (Waltham, MA).  Glacial acetic acid was purchased from VWR international 
(Radnor, PA).  NAP-25 Sephedex G-25 columns were purchased from GE healthcare (Chicago, 
IL).  Bovine Serum Albumin fraction V was purchased from Rockland (Pottstown, PA) and was 
certified immunoglobulin and protease free.  Lysozyme was purchased from MP biomedicals 
(Solon, OH).  The 100 kDa PES flat sheet membranes (UE50) were purchased from Sterlitech 
(Kent, WA).  Fluorescein isothiocyanate isomer 1 was purchased from Alfa Aesar (Haverhill, 
MA).  Dibasic sodium phosphate (ACS grade) was purchased from EMP (Howell, NJ).  Sodium 
chloride bioXtra grade, potassium chloride (99.0%), and monobasic potassium phosphate (ACS 
grade) where purchased from Sigma Aldrich (St. Louis, MO).  CMA 20 microdialysis probes 
were purchased from Harvard Apparatus (Holliston, MA).  CCL2 optiEIA ELISA kit was 
purchased from BD bioscience (San Jose, CA).  Recombinant rat KC/GRO, and mouse aFGF, 
and VEGF Duo set ELISA kits were purchased from R&D systems (Minneapolis, MN).  
Recombinant mouse FGF1 was purchased from Sino Biologicals (Beijing, China) and 
recombinant mouse VEGF was purchased from Life Technologies (Carlsbad, CA).  EDAC-HCl 
was purchased from Amresco (Dallas, TX). 
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Modification to PES Flat Sheets for XPS and ATR-FTIR Analysis 
Initially, the heparin modification procedure was performed on PES flat sheets due to the 
ease of analysis using ATR-FTIR and cost effectiveness compared to microdialysis probes.  
Modification of the 100 kDa PES flat sheets were performed using the procedure described in 
Chapter 4.  Briefly, membranes were allowed to react in the 4HBA polymerization solution for 1, 
2, 3 and 4 days and then were placed in a solution of 0.1 M sodium acetate pH 5.0 overnight to 
wash the membranes.  These membranes were then analyzed with ATR-FTIR.  These 
membranes were then modified with ethylenediamine (ED) in order to attach a primary amine to 
the surface of the carboxyl-functionalized membranes.  This was done by first adding 10 mg of 
1-ethyl-3-(3-dimethylaminopropyl) carbodimide (EDC) to a 30 mL solution of 0.1 M MES 
buffer at pH 5.5 with the flat sheet membranes.  Then 28 mg of sulfo-NHS (N-
hydroxysuccinimide) was added to this solution.  This mixture was allowed to react for 30 
minutes at room temperature.  Next, the membranes were removed from this solution, placed in a 
solution containing 60 mg of ED in 30 mL of PBS (137 mM NaCl, 10 mM phosphate, 2.7 mM 
KCl) at pH 7.4 and allowed to react for 24 hours at room temperature.  The membranes were 
then placed in a solution of PBS pH 7.4 overnight at room temperature.   
To heparin modify the ED modified membranes; the membranes were placed in a 
solution containing 27 mg of EDC and 65 mg of sulfo-NHS in 30 mL 0.1 M MES buffer pH 5.5 
for 30 minutes.  Then, the membranes were placed in a solution containing 30 mg of heparin in 
30 mL of PBS pH 7.4 for 24 hours.  Later, the membranes were removed from the solution and 
rinsed overnight in PBS pH 7.4.  After each modification step the PES flat sheets were placed in 
a desiccator and analyzed using ATR-FTIR.   
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Protein Adsorption to Heparin Modified Membranes 
Protein adsorption was measured to determine if the addition of heparin onto the 
membrane surface would reduce protein adsorption of BSA and lysozyme.  In order to test the 
protein adsorption, BSA and lysozyme were FITC-labeled.  FITC-BSA and FITC-lysozyme 
were made using the procedure described in Chapter 2.  PES flat sheet membranes were initially 
reacted with 4HBA for 0, 1, 8, 12 and 24 hours using the procedure described in Chapter 2.  
After the modification of the membranes with ED, the membranes reacted with heparin 
described above, then the membranes were placed in a solution of FITC-BSA or FITC-lysozyme.  
The concentration was compared with a solution that only contained FITC-BSA or FITC-
lysozyme; based on the difference in fluorescence, the concentration adsorbed onto the surface 
was calculated and converted to protein adsorbed per unit area using Equation 12 in Chapter 2.   
Equilibrium Dialysis Experiments 
Following ATR-FTIR and XPS data (which confirmed the attachment of heparin), 
equilibrium dialysis experiments were performed.  These experiments were performed using an 
equilibrium dialysis chamber with a 1, 2, 3 and 4 day 4HBA modified membranes with heparin 
attached.  These experiments were performed by placing a 25 μL amount of buffer (PBS + 0.1% 
(w/v) BSA) in one chamber, either the PET side or PES side of the membrane and then placing 4 
ng/mL of CCL2 in the opposite chamber.  The samples were then collected after 24 hours, and 
then each side was incubated in a solution of 2 M NaCl in PBS at pH 7.4 for 30 seconds, 1 
minute, 1 hour and 24 hours.  The concentration was then increased to 112 ng/mL to increase the 
likelihood of detecting CCL2 on both sides of the chamber.     
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Nonspecific Adsorption of BSA to the Equilibrium Dialysis Chamber 
To better understand the reasoning behind the sample loss observed in the CCL2 
experiment above, the amount of BSA that nonspecifically adsorbed to the equilibrium dialysis 
surface was calculated. In this experiment, a solution of 0.25 mg/mL of BSA was placed in the 
equilibrium dialysis chamber with no membrane and allowed to incubate for 24 hours.  The 
solution was then removed and the concentration was determined using a standard bicinchoninic 
acid (BCA) assay and compared to the initial solution. 
FITC-10 and Methyl Orange Equilibrium Dialysis Experiment 
To test the equilibrium dialysis chamber and the membranes with a simpler system, 
FITC-10 equilibrium dialysis experiments were performed.  This was done by placing a 100 kDa 
PES flat sheet that had been soaked overnight in PBS pH 7.4 into the chamber.  One side of the 
chamber contained 25 μL of 1.2 mM FITC-10 and PBS was placed on the PES side of the 
membrane.  A 2 μL sample was collected from each side and from the stock solution at 
approximate times of 1, 3, 7 and 22 hours.  These samples were then analyzed by measuring the 
absorbance at 492 nm. 
Since 90 to 95% of the FITC-10 solution adsorbed onto the membrane, this experiment 
was repeated with a 300 kDa PES flat sheet with methyl orange.  Methyl orange has a molecular 
weight of 327 Da.  A 5 mM methyl orange solution was placed on the PET side of the membrane 
and then PBS pH 7.4 was placed on the PES side of the membrane.  Then, 2 μL samples were 
collected from each side at 1, 2, 5 and 24 hours and absorbance values measured at 460 nm.   
Attachment of Heparin to Microdialysis Membranes 
After confirming the attachment of heparin to PES flat sheet membranes the method was 
applied to the modification of microdialysis membranes.  The modification of PES microdialysis 
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membranes was performed by first attaching 4HBA polymers onto the surface using the method 
described in chapter 2.  Briefly this was performed by perfusing a solution containing 28.8 mM 
of 4HBA and 0.5 U/mL of laccase from Trametes versicolor that was dissolved in 0.1 M sodium 
acetate buffer pH 5.0 at a flow rate of 1 μL/min for 2 hours or 24 hours.  Following modification, 
the probe was flushed with 0.1 M sodium acetate buffer pH 5.0 overnight at a flow rate of 3 
μL/min. 
Then, these membranes were modified with ED in order to attach a primary amine to the 
surface of the carboxyl-functionalized membranes.  This is in order to attach heparin using 
EDC/NHS chemistry.  To attach ED, 2 mg of EDC was added to 200 μL of 0.1 M MES buffer at 
pH 5.5.  Then, 5.5 mg of sulfo-NHS was added to this solution.  This mixture was then perfused 
through the microdialysis probe for 45 minutes at 1 μL/min.  Then a solution containing 10 mg 
of ED in PBS at pH 7.4 was perfused through the probe at 1 μL/min for 24 hours.  The probe 
was then flushed with PBS pH 7.4 at 3 μL/min overnight. 
To heparin modify the ED modified microdialysis membranes 4 mg of EDC and 12 mg 
of sulfo-NHS were added to 200 μL of 0.1 M MES buffer pH 5.5.  This mixture was perfused 
through the microdialysis probe for 45 minutes at 1 μL/min.  Then, a solution containing 10 mg 
of heparin in PBS pH 7.4 was perfused through the probe at 1 μL/min for 24 hours.  The probe 
was then flushed with PBS pH 7.4 at 3 μL/min overnight.   XPS was used to confirm the 
attachment of 4HBA polymers and heparin.  
FITC-Dextran and Lysozyme Relative Recovery Experiments 
To test how this modification affected the membrane surface a FITC-4 RR experiment 
was performed.  CMA20 microdialysis probes were modified with 4HBA polymer for 24 hours 
ED, and heparin.  Then, between each step FITC-4 RR was measured.  The FITC-4 RR 
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experiment was performed by perfusing with PBS at pH 7.4 (perfusion fluid) at a flow rate of 1 
μL/min through a microdialysis probe placed in a solution containing 500 μM FITC-4 in 
perfusion fluid.  Samples were collected every 20 minutes for a total of 60 minutes, and 
absorbance values were measured in triplicate for each sample at 493 nm. Concentrations were 
determined using a calibration curve generated that day. Also FITC-4, FITC-10, and FITC-20 
RR was determined for 2 hour and 24 hour 4HBA-heparin modified microdialysis membranes. 
Also, RR of lysozyme was performed using 500 μg/mL of lysozyme with a perfusion fluid of 
PBS at pH 7.4 at a flow rate of 1 μL/min.  Samples were collected every 30 minutes for a total of 
2 hours and were analyzed using a standard BCA assay.   
KC/GRO Relative Recovery Experiment 
 After confirming the attachment of heparin onto microdialysis membranes the relative 
recovery of KC/GRO was obtained.  For KC/GRO RR experiments, control and 24 hour heparin 
modified microdialysis probes were compared.  To determine the RR the probes were placed in a 
solution containing 2,000 pg/mL of KC/GRO in PBS 0.1% BSA at pH 7.4.  Microdialysis probes 
were perfused at 1 μL/min with PBS 0.1% BSA at pH 7.4 and samples were collected every hour 
for a total of 4 hours.  The samples were then analyzed using a standard KC/GRO ELISA kit. 
Heparin Binding Protein Relative Recovery Experiments 
Next, RR of three heparin binding protein was determined.  For these experiments, 2 hour 
and 24 hour 4HBA modified and heparin modified microdialysis probes, were compared with 
control (unmodified) microdialysis probes.  To determine the RR of these analytes, the probes 
were placed in a solution containing 6 ng/mL of CCL2, 800 ng/mL of aFGF, or 200 ng/ml of 
VEGF in PBS 0.1% BSA at pH 7.4. Probes were perfused with PBS 0.1 % BSA at pH 7.4 at 1 
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μL/min.  Samples were collected every hour for a total of 4 hours and analyzed using a standard 
CCL2, aFGF, or VEGF ELISAs. 
Results and Discussion 
ATR-FTIR Analysis of ED and Heparin Modified PES Flat Sheets 
To confirm the attachment of heparin onto PES flat sheet membranes, XPS and ATR-
FTIR analyses were performed.  The ATR-FTIR results show the presence of a carboxylic acid 
functional group by the peak at approximately 3300 cm
-1
 in Figure 33(A), shown for comparison 
purposes from Chapter 2.  Upon modification with ED as shown in Figure 33(B), there is a 
disappearance of the peak at approximately 3300 cm
-1
 indicating that the primary amine reacted 
with the carboxylic acid functional group that was present in the 4HBA modified membranes.  
Also, the weak peak at 3300 cm
-1
 could indicate remaining carboxylic acid or a secondary amine.  
In Figure 34, the PET side shows water is not present in the membrane and that ED does not 
react with the PET side of the membrane. 
The next step was to attach heparin to the ED functionalized membranes. After 
modification with heparin ATR-FTIR analysis was performed on the membranes.  As seen in 
Figure 35 there is an increase in the peak at approximately 3300 cm
-1
 indicative of the hydroxyl 
functional groups on heparin.  This peak is not present in the ED functionalized membranes 
shown in Figure 33(B).  Moreover, the PET side (Figure 36) shows the absence of water and that 
the reaction is selective for the PES side. 
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Figure 33. (A) IR spectra of the PES side of flat sheet membranes modified with 4HBA for 
0 (PES), 1, 2, 3, and 4 days.  (B) IR spectra of the PES side of flat sheet membrane for 0 
(PES), 1, 2, 3, and 4 day modifications with 4HBA after attachment of ED. 
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Figure 34.  IR spectra of the PET side of flat sheet membrane for PES, 1 day modification, 
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of 
ED. 
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Figure 35.  IR spectra of the PES side of flat sheet membranes for PES, 1 day modification, 
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of 
heparin. 
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Figure 36.  IR spectra of the PES side of flat sheet membranes for PET, 1 day modification, 
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of 
heparin. 
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Analysis of PES Flat Sheets Modified with Heparin using XPS 
The next step was to analyze the heparin modified membranes using XPS.  This was done 
to further confirm the attachment of heparin on the membrane surface.  The results from XPS 
analysis, shown in Table 12, show the presence of S2p in the heparin modified membranes.  
Since heparin is highly sulfonated, the presence of S2p indicates the presence of heparin.  There 
is also a decrease in the presence of the C-S functional groups for the heparin modified 
membranes and a decrease in the C-S present in the 4HBA modified membranes.  The C-S 
functional group is found only in the sulfone group on PES so the decrease in C-S indicates the 
addition of a substance onto the surface (4HBA, and heparin).  There is also a significant 
increase in the COOH functional groups for the 4HBA modified membranes, and for the heparin 
modified membranes.  Also, the binding energy of the COOH functional groups for the 4HBA 
and heparin modified membranes are different.  This indicates a different chemical environment 
which would be expected because 4HBA and heparin have different structures. There was also 
no significant change in the C-H/C-C content.  In addition, there was also no significant 
difference in the heparin modified membranes based on the length of 4HBA modification 
between 1 and 4 day modification.  
 
  
 
 
 
Table 12. Three PES flat sheet membranes analyzed using XPS. Percentages are determined from the peak areas of the C1s, 
O1s, and S2p high resolution XPS spectra.  * indicates a significant difference from the sodium acetate control, 4HBA control, 
and 3Cl4HBA control at the 95% confidence level using a single factor ANOVA with Bonferroni post hoc test.  ND indicates 
not detected (<0.1 atom%).  For statistical analysis ND values were replaced with the detection limit (0.1 %). 
 
 C-C/C-H C-O-C C-S O-C O-S 
COOH-
4HBA 
COOH-
heparin 
S2p S2p 
Binding Energy 
(eV) 
284.77 
±0.027 
286.25 
±0.080 
288.82 
±0.097 
531.73 
±0.15 
533.43 
±0.14 
287.45 
±0.18  
287.85 
±0.14 
167.67 
±0.059 
168.87 
±0.068 
Control 
55.32 ± 
3.33% 
13.89 ± 
0.95% 
7.79 ± 
0.95% 
12.54 ± 
0.96% 
10.46 ± 
1.07% 
ND ND ND ND 
Laccase Control 
47.00 ± 
5.47% 
23.28 
±0.89%* 
8.51 ± 
0.57% 
14.06 ± 
4.38% 
7.15 ± 
1.32% 
ND ND ND ND 
4HBA Control 
57.25 ± 
0.78% 
13.05 ± 
2.97% 
7.20 ± 
0.79% 
13.09 ± 
1.43% 
9.41 ± 
1.40% 
ND ND ND ND 
4HBA Modified 
58.26 ± 
4.34% 
11.68 ± 
1.41% 
3.50 ± 
1.10%* 
14.40 ± 
6.96% 
3.59 ± 
1.36%* 
8.57 ± 
0.83%* 
ND ND ND 
1 Day-4HBA-
Heparin 
61.27± 
6.27% 
8.42 ± 
1.98% 
ND* 
16.97 ± 
1.35% 
2.32 ± 
1.80%* 
ND 
5.29 ± 
2.23%* 
1.50 ± 
0.11%* 
0.92 ± 
0.27%* 
2 Day 4HBA-
Heparin 
56.50 ± 
0.12% 
7.82 ± 
1.16% 
ND* 
19.51 ± 
1.07% 
2.07 ± 
0.77%* 
ND 
7.33 ± 
0.16%* 
1.20 ± 
0.18%* 
0.77 ± 
0.02%* 
3 Day 4HBA-
Heparin 
57.55 ± 
0.97% 
7.52 ± 
0.91% 
ND* 
18.53 ± 
0.41% 
3.18 ± 
0.40%* 
ND 
5.99 ± 
1.27%* 
1.46 ± 
0.06%* 
0.87 ± 
0.07%* 
4 Day 4HBA-
Heparin 
58.64 ± 
1.00% 
7.14 ± 
1.25% 
ND* 
17.38 ± 
1.01% 
2.89 ± 
0.22%* 
ND 
6.63 ± 
0.90%* 
1.58 ± 
0.04%* 
0.97 ± 
0.15%* 
1
1
3
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FITC-BSA and Lysozyme Adsorption  
 To analyze protein adsorption onto the heparin modified PES flat sheets, BSA and 
lysozyme adsorption were determined.  This experiment was performed by using PES flat sheets 
that were modified with 4HBA for the specified time shown (Figure 37 and 38), and then reacted 
with ED and heparin.  The results for FITC-lysozyme show an increase in protein adsorbed as 
the 4HBA modification time increased (Figure 37).  This could be due to an increase in the 
amount of heparin on the surface and/or the increase in unreacted 4HBA on the surface.  Since 
the protein adsorption increased with heparin modification that could indicate a charge-charge 
interaction between the negatively charge membrane surface with an overall positively charged 
for lysozyme.  For FITC-BSA (Figure 38), there was no significant difference between the 
control membranes and the membranes modified with heparin.  This shows that BSA adsorption 
does not decrease upon addition of heparin to the membrane surface. 
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Figure 37.  Lysozyme adsorption onto PES membranes modified with 4-hydroxybenzoic 
acid (4HBA) polymers for 1, 8, 12, and 24 hours then heparin modified compared to 
control PES membranes. N=3 * indicates a significant difference at the 95% confidence 
level compared the control using a single factor ANOVA with Bonferroni post hoc test.  
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Figure 38.  BSA adsorption onto PES membranes modified with 4-hydroxybenzoic acid 
(4HBA) polymers for 1, 8, 12, and 24 hours then heparin modified compared to control 
PES membranes. N=3, * indicates a significant difference at the 95% confidence level 
compared the control using a single factor ANOVA with Bonferroni post hoc test.  
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Equilibrium Dialysis Experiments 
Equilibrium dialysis experiments were performed to provide a way to test the transport 
across the PES flat sheet membranes modified with heparin.  An initial experiment was 
performed to test if by placing the affinity agent on the same side or opposite side of the target 
(CCL2), it would increase transport. The results from this experiment (Table 13) show that 
placing the affinity agent and the target on the same side showed a non-detectable concentration 
for each side of the membrane.  This could be due to the binding of CCL2 to the heparin side 
making the levels not detectable in solution.  Also, by placing the CCL2 on the PET side and the 
heparin modification being on the PES side, CCL2 was observed on the PET side. However, 
CCL2 was only detected on the heparin modification side for the 2 day 4HBA modified, heparin 
modified membrane.  This could be due to the binding on the heparin and CCL2.  The samples 
collected after incubation with 2 M NaCl showed non-detectable concentrations of CCL2 
indicating that the bound CCL2 was not removed by the addition of NaCl.    
The concentration of CCL2 was then increased to 112 ng/mL (Table 14) observable 
concentrations of CCL2, however when this experiment was repeated, concentrations of CCL2 
were not detectable.  This could be due to the binding of CCL2 to the membrane surface and 
blocking pores since a significant portion of the 112 ng/mL CCL2 concentration was lost to the 
equilibrium dialysis chamber and the membrane. 
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Table 13.  Equilibrium dialysis experiment using 4,000 pg/mL of CCL2 placed on either the 
same side or opposite side of the heparin modification inside the chamber for 24 hours.   
Samples were then collected from each side and analyzed using a CCL2 ELISA.  ND= not 
detected (<31 pg/mL). 
 
Opposite Side 
  
Same Side 
4HBA Reaction 
Time (Days) 
Heparin 
PES 
(pg/mL) 
PET with 
CCL2 
(pg/mL) 
4HBA Reaction 
Time (Days) 
Heparin 
PES 
(pg/mL) 
PET (pg/mL) 
1 ND 480 1 ND ND 
2 270 1110 2 ND ND 
3 ND 450 3 ND ND 
4 ND 450 4 ND ND 
PES  ND ND PES  ND ND 
 
Table 14.  Equilibrium dialysis experiment using 112 ng/mL of CCL2 placed on the 
opposite side of the heparin modification inside the chamber for 24 hours.  Samples were 
then collected from each side and analyzed using a CCL2 ELISA.   
 
4HBA Reaction Time (Days) Heparin side (PES) (ng/mL) PET side (ng/mL) 
1  10.4 0.3 
2  13.8 0.5 
3  1.8 0.3 
4  2.7 0.1 
 
Nonspecific Adsorption of BSA to the Equilibrium Dialysis Chamber 
 BSA adsorption to the equilibrium dialysis chamber was calculated to determine to what 
extent protein is adsorbing onto the equilibrium dialysis chamber.  The determined amount of 
loss of BSA to the equilibrium dialysis chamber was 0.54 μg/cm2 this was 23% of the original 
BSA added to the container.  Although the experiments performed with CCL2 did have a 
concentration of 0.1% BSA as a blocking agent, this could explain some of the loss of the 
analyte (CCL2).   
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FITC-10 and Methyl Orange Equilibrium Dialysis Experiments  
FITC-10 and methyl orange equilibrium dialysis experiments were performed in order to 
provide a simpler system to better understand the sample loss that is occurring in these 
equilibrium dialysis experiments.  The results for this experiment (Figure 39) show that 
compared to the starting concentration, the PET side decreases in concentration. However, the 
PES side did not increase as rapidly to match the decrease in concentration from the PET side.  
This indicates that the FITC-10 is either adsorbed onto the material and/or trapped inside the 
pores which can be visibly seen by a yellow color when the membrane is removed from the 
module.  
Since FITC-10 was adsorbing to the membrane surface with the 100 kDa PES flat sheets, 
an experiment was performed with methyl orange with 300 kDa PES flat sheets.  The data from 
this experiment (Figure 40) show a decrease in the concentration of the PET side compared to 
the starting concentration.  The PES side does not show a corresponding increase in methyl 
orange concentration, indicating that the methyl orange is trapped inside the membrane.  
Although equilibrium is reached between hours 2 and 5 indicated by the absorbance values being 
almost identical, there is still significant loss of the methyl orange to the membrane surface 
which is observed by the orange color of the membrane.   
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Figure 39.  Equilibrium dialysis data for FITC-10 on 100 kDa PES flat sheet membranes.  
The side of the chamber that exposed the PES side of the membrane contained the initial 
FITC-10 solution labeled PES above and the side of the chamber that exposed the PET side 
of the membrane labeled PET above.  Both sides of the chamber were analyzed. 
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Figure 40.  Equilibrium dialysis data for methyl orange for 300 kDa PES flat sheet 
membranes.  The side of the chamber that exposed the PES side of the membrane 
contained the initial FITC-10 solution labeled PES above and the side of the chamber that 
exposed the PET side of the membrane labeled PET above.  Both sides of the chamber were 
analyzed. 
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Conclusions from Equilibrium Dialysis Experiments 
 After confirming the attachment of heparin on the PES flat sheets but determining that 
transport across these flat sheets was hindered by the analyte adsorbing onto the membrane 
surface and/or pores, microdialysis experiments were performed.  The reason for making this 
decision was based on previous research which showed that analytes could be collected in the 
dialysate using microdialysis.  The overall goal of using the flat sheet membranes was to 
understand the chemistry to attach heparin onto the surface.  This was successful in confirming 
the attachment of heparin onto the PES flat sheet membranes.  The information provided through 
the equilibrium dialysis experiments could provide insight into mass transport enhancement 
however these membranes are typically used in pressurized systems and are rated for such 
systems, so it was difficult to see transport using an equilibrium dialysis chamber.  Applying a 
pressurized system for cytokine collection would be difficult due to the increase in sample size 
that would be needed.   
  
 123 
 
 
Effect of Heparin Modification of Microdialysis Membranes on Relative Recovery of 
Heparin Binding Proteins 
After confirming the attachment of heparin to PES flat sheets, the method was applied to 
the membrane of microdialysis probes.  To confirm the attachment of heparin to microdialysis 
membranes XPS analysis was performed and then the RR experiments were performed. Initially 
FITC-4, FITC-10, and FITC-20 were used to determine if heparin modification reduced RR 
significantly due to pore blockage caused by the modification.  Next, RR of three heparin 
binding proteins (CCL2, VEGF, and aFGF) was determined as well as KC/GRO.  The reason for 
choosing these heparin binding proteins was that CCL2 has a slow off rate compared to VEGF, 
and aFGF.  This will test if RR enhancement is affected by the off rate.  
Modification of Microdialysis Membranes with Heparin 
XPS analysis was performed on microdialysis membranes in order to confirm the 
attachment onto the membrane surface.  Results from XPS analysis, Table 15, show that the 
carboxylic acid functional group is found in the heparin modified membranes and not present in 
the control membranes.  There is also a decrease in the C-S functional group to below detectable 
levels upon modification with heparin.  Also, there is a significant increase in the percentage of 
sulfur 2p found in heparin modified membranes.  The carboxylic acid functional group is found 
in both heparin and 4HBA modifications, but the increase in the amount S2p present can only 
come from the addition of heparin to the membrane surface which confirms the attachment of 
heparin to the microdialysis membrane. 
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Table 15.  XPS data from control 4HBA and heparin modified microdialysis membranes.  
Percentages are determined from the peak areas of the C1s, O1s, and S2p high resolution 
XPS spectra.  * indicates a significant difference from the control at the 95% confidence 
level using a single factor ANOVA with Bonferroni post hoc test.  # indicates significant 
difference from the 4HBA modified MD membrane at the 95% confidence level.  ND 
indicates not detected (<0.1%).  
 
  C-C/C-H C-O COOH S2p O-C O-S 
Binding Energy 
(eV) 
284.64 ± 
0.15 
285.75 ± 
0.38 
287.72 ± 
0.35 
167.89 ± 
0.17 
531.82 ± 
0.32 
533.54 ± 
0.24 
Control 54.65 ± 
10.40% 
22.54 ± 
6.76% ND 
3.12 ± 
1.14%# 
15.14 ± 
5.07% 
3.15 ± 
0.64% 
4HBA Modified 49.83 ± 
11.88% 
17.68 ± 
6.50% 
9.73 ± 
5.94%* 
0.85 ± 
0.18%* 
14.81 ± 
4.36% 
ND 
Heparin Modified 56.60 ± 
4.66% 
22.35 ± 
17.93% 
3.23 ± 
2.86%* 
2.31 ± 
0.49%# 
22.30 ± 
11.52% 
ND 
 
FITC-Dextran and Lysozyme Relative Recovery  
After confirming the attachment of heparin to microdialysis probes RR experiments were 
performed.  First FITC-4 RR was analyzed to determine if the modification with heparin blocked 
pores inhibiting the RR.  FITC-4 relative recovery was determined for microdialysis membranes 
initially, and after 4HBA, ED, and heparin modifications.  This was determined to see if 
recovery of FITC-4 would be affected by the modification.  The results from this experiment 
(Figure 41) show a significant decrease in the RR of FITC-4 after modification with 4HBA 
polymerization solution for 24 hours.  The RR for FITC-4 does not change after modification 
with ED and heparin, indicating that after modification for 24 hours with 4HBA, that the 
addition of ED and heparin does not further decrease the RR of FITC-4.  After testing the RR for 
FITC-4 with a 24 hour 4HBA modification time, the RR was analyzed with 2 hour and 24 hour 
4HBA-heparin modified probes and compared to the control for FITC-4, FITC-10, and FITC-20 
as well as lysozyme.  For FITC-4 (Figure 42), FITC-10 (Figure 43), and FITC-20 (Figure 44), 
the RR was significantly lower after heparin modification compared to the control.  For  
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FITC-4 and FITC-20 the decrease in RR for heparin modified membranes when compared to the 
4HBA modification was not significantly different for the 24 hour modification time but was 
significantly lower for the 2 hour modification time.  For FITC-10, RR for the 2 hour 4HBA 
modification time before and after heparin modification was not significantly different but FITC-
10 RR was significantly higher for the 24 hour modification time after heparin modification 
compared to before heparin modification.   
 
 
Figure 41.  FITC-4 relative recovery for the same control, 24 hour 4HBA, ethylenediamine, 
and heparin modified microdialysis probes. N=3 *indicates a significant difference at the 
95% confidence level compared the control using a two factor ANOVA with Bonferroni 
post hoc test.  
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Figure 42.  FITC-4 relative recovery for control, 2, and 24 hour 4HBA-heparin modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.   
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Figure 43.  FITC-10 relative recovery for control, 2, and 24 hour 4HBA-heparin modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.   
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Figure 44.  FITC-20 relative recovery for control, 2, and 24 hour 4HBA-heparin modified 
microdialysis probes.  N=3, * indicate significant difference at the 95% confidence level 
using a two factor ANOVA with Bonferroni post hoc test.   
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Figure 45.  Lysozyme relative recovery for control, 2 hour, and 24 hour 4HBA-heparin 
modified microdialysis probes.  Probes were placed in a solution containing 500 μg/mL of 
lysozyme.  N=3   
 
Lysozyme RR, shown in Figure 45, shows no significant difference between the control 
and after heparin modification regardless of 4HBA modification time.  What is interesting about 
this is that for the 24 hour 4HBA modification, the RR was below the detection limit of the assay 
(25 μg/mL); upon modification with heparin the RR increased to a value that was not 
significantly different than the control RR.   
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Relative Recovery of KC/GRO for Control, 2 Hour and 24 Hour 4HBA-Heparin Modified 
Microdialysis Membranes 
 Next RR for KC/GRO was tested with control, 2 and 24 hour heparin modified 
microdialysis membranes.  KC/GRO was also analyzed because the human analog of rat 
KC/GRO is IL-8 which is a known heparin binding protein.
139
  The reason for testing this analyte 
was to see if RR enhancement could be observed which could be an indication of KC/GRO 
binding to heparin.  The results for this experiment (Figure 46) show no enhancement in RR for 
the 24 hour 4HBA-heparin modified membranes compared to the control membranes.  For the 2 
hour 4HBA-heparin modified membranes relative recovery approximately doubled.  This could 
indicate that KC/GRO is binding to the heparin modification on the membrane surface.  The 
increase in RR could also be due to a charge-charge interaction between the negatively charge 
surface and KC/GRO because the results are similar to what was observed for the 2 hour 4HBA 
modified microdialysis membranes.  This could indicate that the heparin modification is also 
reducing nonspecific adsorption of KC/GRO leading to an increase in RR.         
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Figure 46.  Box and whiskers plot of KC/GRO relative recovery of control 2 hour and 24 
hour 4HBA-heparin modified microdialysis probes.  N=3 * Indicates significantly different 
than the control at the 95% confidence level as determined by a 2 factor ANOVA with 
Bonferroni post hoc test. 
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Relative Recovery of CCL2, aFGF, and VEGF for Control, 2 Hour, and 24 Hour 4HBA-
Heparin Modified Microdialysis Membranes 
RR was calculated for CCL2, aFGF and VEGF.  These three analytes are known heparin 
binding proteins and also have both fast (VEGF, aFGF) and slow off rates (CCL2).  These are 
known heparin binding proteins, so RR was determined to test if by adding heparin as an affinity 
agent to the membrane surface would increase RR.  From this information more insight will be 
given into the factors that affect the RR enhancement by affinity agents like heparin. 
 For the 24 hour 4HBA-heparin modified microdialysis probes, there is a significant 
increase in RR observed for hours 2 to 4 (Figure 47).  The increase at hour 2 is approximately 
20% and for hours 3-4 is close to 100%.  For the 2 hour 4HBA-heparin modified microdialysis 
probes, there is no significant difference between the control and the 2 hour 4HBA-heparin 
modified microdialysis probes (Figure 48).  For the 24 hour 4HBA-heparin modified 
membranes, the RR increase after hour 1 may be that the rate of binding of CCL2 to heparin is 
faster than the rate of release.  After hour 1 an equilibrium phase where the rate of binding and 
releasing is equal; this allows for the increase in RR due to the blocking of irreversible binding 
sites by the addition of heparin onto the membrane surface.  For the 2 hour 4HBA-heparin 
modified microdialysis membranes there may be insufficient heparin on the surface to observe a 
significant increase in RR. 
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Figure 47.  Box and whiskers plot of CCL2 RR of control and 24 hour 4HBA-heparin 
modified MD probes.  N=6 for control, and N=3 for 24 hour 4HBA-heparin modified MD 
probes.  * indicates significance at the 95% confidence level. 
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Figure 48.  Box and whiskers plot of CCL2 RR of control and 2 hour 4HBA-heparin 
modified MD probes.  N=6 for control MD probes and N=3 for 2 hour 4HBA-heparin 
modified microdialysis probes.  
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Figure 49.  Box and whiskers plot of aFGF relative recovery of control, 2 hour and 24 hour 
4HBA-heparin modified MD probes.  N=3.  * indicates significance at the 95% confidence 
level. 
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 The next analyte that was tested was aFGF which has a fast off rate compared to CCL2.  
The results from the aFGF in vitro microdialysis experiment in Figure 49 show a significant 
increase in RR after hour 2 for the 2 hour 4HBA-heparin modified microdialysis probes.  The 
RR for 24 hour 4HBA-heparin modified microdialysis probes did not change significantly.  
CCL2 is 13.1 kDa (pI 9.25) and is slightly smaller than aFGF at 15.5 kDa (pI 5.6).  Since aFGF 
is approximately 2 kDa larger in mass compared to CCL2, the 24 hour 4HBA modification time 
may exclude more of the aFGF compared to the CCL2. This may be the reason the RR for aFGF 
did not increase for the 24 hour 4HBA-heparin modified microdialysis membranes.  For the 2 
hour 4HBA-heparin modifications since aFGF has a slightly higher on-rate and a faster off rate, 
more heparin may not need to be bound to the surface in order to see RR enhancement.   
Next, VEGF relative recovery was determined for control, 2 hour and 24 hour 4HBA-
heparin modified microdialysis membranes.  VEGF RR results for 2 hour 4HBA-heparin 
modified and 24 hour 4HBA-heparin modified membranes are shown in Figure 50.  For the 24 
hour 4HBA-heparin modification there was a significant difference in RR for VEGF compared 
to the control.  The increase in RR observed is slight compared to the control.  VEGF is larger at 
21 kDa than CCL2 and aFGF at 13.1 and 15.5 kDa.  Since it is known that the modification with 
4HBA can decrease the pore size, especially at the 24 hour reaction time, the transport of VEGF 
RR may decrease more due to the pore size decrease than can be compensated for by the affinity 
interaction on the membrane surface.  This could also explain why there is no significant 
difference in the RR for the 2 hour 4HBA-heparin modification because there is possibly less 
heparin on the surface.   
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Figure 50.  Box and whiskers plot of VEGF relative recovery of control, 2 and 24 hour 
4HBA modified microdialysis probes.  N=3  * Indicates significantly different than the 
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni 
post hoc test. 
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With the attachment of heparin onto the membrane surface, RR of CCL2, aFGF, and 
VEGF were analyzed.  CCL2 RR increased twofold at hours 3 and 4 for the 24 hour 4HBA-
heparin modification.  For aFGF RR for the 2 hour 4HBA-heparin modified MD probes 
increased twofold for hours 3 and 4.  CCL2 is smaller at 13.1 kDa than aFGF at 15.5 kDa.  Since 
the 24 hour modification is shown to inhibit transport this could explain why the increase in RR 
for aFGF is not observed for the 24 hour modification time.  This may also explain why the 
increase in RR for VEGF is also small for the 24 hour modification time because VEGF is 21 
kDa. 
Conclusions 
This chapter shows successful attachment of heparin on to PES flat sheets and 
microdialysis membranes shown by XPS and ATR-FTIR analysis.  Protein adsorption 
experiments show no significant change in adsorption for BSA and an increase in adsorption of 
lysozyme for 12 and 24 hour modification times.  Equilibrium dialysis experiments were 
attempted with heparin modified flat sheets but there was a high amount of analyte binding to the 
membrane surface and pores.  FITC-4, FITC-10, and FITC-20, RR was calculated and showed 
that upon addition of ED and heparin that the recovery did not decrease compared to the initial 
decrease from addition of 4HBA.  Relative recovery of CCL2 increased 2 fold at hours 3 and 4 
and for VEGF at all collection times for the 24 hour 4HBA-heparin modified membranes.  These 
RR enhancements were less than what was observed with using heparin-immobilized 
microspheres for CCL2 and VEGF of 4 fold and 2 fold increases, but this could be due to the 
reduction in pore size due to the modification.
53
  This could be improved upon by testing 
different 4HBA, and heparin modification times.  Also aFGF showed a 2 fold increase in RR for 
hours 3 and 4 for 2 hour 4HBA-heparin modified membranes.  This increase in RR was not 
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observed under the same flow rate conditions of 1 μL/min with heparin modified microspheres 
so by adding heparin to the membrane surface the RR was enhanced twofold which is an 
improvement on the previously used method.
53
  By doubling the RR the concentration required 
to detect these analytes is reduced by half.  For example for CCL2 the detection limit for the 
ELISA assay is 31 pg/mL so with a RR of 3.84% the minimum amount of CCL2 needed outside 
the probe to be detected by this assay would be 806 pg/mL.  With the 24 hour 4HBA-heparin 
modification with an average RR of 6.56% at hours 3 and 4 the required amount of CCL2 needed 
outside the probe would be 472 pg/mL.  By increasing the RR the analyte is able to be detected 
at a lower concentration.  If the analyte is indicative of the onset of a specific condition or 
disease being able to detect this analyte at a lower concentration could ultimately lead to 
detecting the condition or disease marker sooner. 
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CHAPTER 6.  CONCLUSIONS AND FUTURE PROSPECTS 
 
 Microdialysis is a technique which has the ability to sample the extracellular fluid space 
surrounding the membrane but one of the challenges to this technique is the ability to sample 
proteins which have low relative recovery and are at low concentrations (ng/mL-pg/mL range).  
This introduces a problem in detecting these proteins.  An approach to solving this problem is to 
increase the relative recovery of these proteins across the microdialysis membrane.  By 
increasing the relative recovery the amount of analyte external to the probe needed to detect this 
analyte is reduced.  For example is the relative recovery is doubled then the external 
concentration needed for detection by the assay is reduced by half.   
Introduction of perfusion fluid additives, such as BSA, antibodies, and heparin, have been 
previously shown to increase relative recovery.
7
    These perfusion fluid additives look at two 
different approaches to increasing relative recovery: reducing nonspecific adsorption (BSA), and 
introducing an affinity interaction (heparin, antibodies).  In this dissertation the membrane 
surface was modified in order to study the enhancement of relative recovery using these two 
different methods.  To study the enhancement of relative recovery by reducing nonspecific 
adsorption, 4-hydroxybenzoic acid polymers were covalently added to the membrane surface 
using a laccase catalyzed reaction.  To study the effect of relative recovery by attaching an 
affinity agent, heparin was attached to the membrane surface.    
Conclusions 
To study how the addition of 4-hydroxybenzoic acid polymers altered relative recovery in 
microdialysis, a method was devised to modify the microdialysis membrane surface using the 
enzyme laccase.  Laccase catalyzes the one-electron oxidation of four reducing-substrate 
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molecules followed by the four-electron reduction of molecular oxygen to water.
91
  The overall 
outcome of the catalytic cycle is the reduction of one molecule of oxygen to two molecules of 
water and the concomitant oxidation of 4 substrate molecules to produce 4 radicals.
91
  These 
4HBA radicals can then react with the PES surface as well as with other 4HBA molecules. The 
reaction between 4-hydroxybenzoic acid and laccase was used to generate 4HBA polymers onto 
the microdialysis membrane surface.     
Confirmation of attachment of 4-hydroxybenzoic acid polymers onto PES flat sheets was 
shown by the presence of hydroxyl peak from a conjugated carboxylic acid at approximately 
3300 cm
-1
 on the IR spectrum, and the presence of carboxylic acid peak at 287.85 eV, a decrease 
in C-S at 288.81 eV, and a decrease in O-S at 533.35 eV from C1s and O1s high resolution XPS 
spectra.  After confirming the attachment of 4-hydroxybenzoic acid polymers onto PES flat 
sheets, BSA and lysozyme adsorption was analyzed and showed an initial increase in BSA 
adsorption followed by a decrease in BSA adsorption with increasing modification time.  This 
shows that in order to see reduction in nonspecific adsorption the amount of polymer on the 
surface in terms of both graft density and chain length must be reached in order to exclude BSA 
adsorption onto the surface.  Lysozyme protein adsorption increased upon modification with 4-
hydroxybenzoic acid possibly due to both charge-charge interactions with the carboxylic acid 
functional groups and insufficient graft density to exclude lysozyme from binding to the surface. 
After confirming the attachment of 4-hydroxybenzoic acid polymers onto PES flat sheet 
membranes the reaction was performed on PES microdialysis probes and the attachment was 
confirmed using XPS by the introduction of a carboxylic acid peak at 387.90 eV and the 
reduction of the O-S peak at 532.99 eV to a non-detectable level.  Two different modification 
times were chosen, 2 and 24 hours.  FITC-4, FITC-10, and FITC-20 relative recovery was 
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initially tested to determine if the modification times selected inhibited transport across the 
membrane; it was confirmed that the 24 hour modification time reduced relative recovery by 60-
70% and the 2 hour modification reduced relative recovery by 20-40%.  To further confirm this 
reduction in relative recovery upon modification with 4-hydroxybenzoic acid, lysozyme relative 
recovery was not detected for the 24 hour modification, and the 2 hour modification was not 
significantly different than the control (no modification).  Since the adsorption of BSA and 
lysozyme onto the PES flat sheets indicated that the adsorption was influenced by charge-charge 
interactions between the adsorbing molecule and the surface, relative recovery was analyzed for 
both proteins with pI greater and less than pH 7.4.  These analytes were CCL2 (pI= 9.3), 
KC/GRO (pI= 9.1), and VEGF (pI= 8.5), which have isoelectric points greater than pH 7.4 and 
TNF-α (pI= 5.0), and aFGF (pI= 5.7), which have isoelectric points less than pH 7.4.  The 
relative recovery results from these analytes showed a 2 to 3 fold increase in relative recovery for 
analytes that had an isoelectric point greater than pH 7.4 (CCL2, KC/GRO, VEGF) but no 
significant increase in relative recovery for analytes with isoelectric points less than pH 7.4 
(TNF-α, aFGF) for the 2 hour 4-hydroxybenzoic acid modified microdialysis probes.           
After analyzing the effect of the 4-hydroxybenzoic acid modification on relative 
recovery, this modification was used to further modify the membrane surface with heparin.  This 
was performed by a two-step process, attaching ethylenediamine to the carboxylic acid modified 
membrane surface, and then attaching heparin to the amine modified membrane surface, both 
using EDC/NHS chemistry.  Attachment of ethylenediamine and heparin was confirmed by the 
disappearance of the peak at 3300 cm
-1
, indicating that the surface did not contain the carboxylic 
acid functional group at a significant quantity to be detected using ATR-FTIR; heparin 
modification was confirmed by the reappearance of the peak at 3300 cm
-1
, indicating the 
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presence of the carboxylic acid functional group.  XPS results for the heparin modified flat 
sheets showed peaks at 287.85 eV indicative of the carboxylic acid functional group and 167.67 
eV, and 168.87 eV for S2p.  There was also a decrease in C-S at 288.82 eV.  BSA and lysozyme 
protein adsorption to the PES flat sheet membrane showed no change in BSA adsorption, but an 
increase in protein adsorption for the 12 and 24 hour modification times for lysozyme.  This 
increase in protein adsorption could indicate a charge-charge interaction between the highly 
negatively charged heparin and the overall positively charge lysozyme. 
After confirming the attachment of heparin onto PES flat sheets the method was applied 
to PES hollow fiber microdialysis probes.  XPS results show the presence of a carboxylic acid 
peak at 287.72 eV ± 0.35 at 3.23% ± 2.86 for the heparin modified microdialysis membranes, 
which is not detected for the control membranes.  Also the O-S peak at 533.54 eV ± 0.24 for the 
heparin modified membranes was not detectable compared the control at 3.15% ± 0.64.  The S2p 
peak is also greater than the S2p peak in the 4HBA modified microdialysis membrane.   
After confirming the attachment of heparin to PES microdialysis membranes FITC-4, 
FITC-10, and FITC-20 relative recovery was determined and showed no further decrease in 
relative recovery compared to the decrease in relative recovery after modification with 4HBA.  
Relative recovery for heparin binding proteins, CCL2, aFGF, and VEGF, was determined.  
CCL2 showed a twofold increase in relative recovery for hours 3 and 4 for the 24 hour 4HBA-
heparin modifications time.  This RR enhancement was less than the observed fourfold RR 
enhancement with heparin immobilized microspheres but by doubling the RR with the 24 hour 
4HBA-heparin modified surface this is still considered to be an improvement compared to using 
an unmodified microdialysis membrane.
53
  The increase in RR CCL2 for the 24 hour 4HBA-
heparin modification could be due to the increase in heparin on the membrane surface with 
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increased 4HBA modification time but the size of CCL2 is not significantly blocked by the 
increase in modification.  This may also explain why the RR enhancement was less than what 
was observed with the heparin-immobilized microspheres because the pore size of the membrane 
is, as was observed with the FITC-labeled dextrans, being reduced.  
For aFGF the RR increased twofold for the 2 hour 4HBA-heparin modification.  This was 
not observed under the flow rate conditions (1μL/min) with perfusing heparin immobilized 
microspheres so adding heparin to the membrane surface provided more significant enhancement 
to RR compared to using heparin immobilized microspheres under the same flow rate 
conditions.
53
  For the aFGF molecular weight is greater than CCL2 so aFGF may be blocked by 
the 24 hour 4HBA-heparin modification which could explain why the RR did not increase with 
the 24 hour 4HBA-heparin modification.   
VEGF relative recovery was significantly different than the control for the 24 hour 
4HBA-heparin modification time.  VEGF (21 kDa) relative recovery for 24 hour 4HBA-heparin 
modified membranes was significantly different than the control but the increase in relative 
recovery was slight this could be due to pore blockage caused by the 24 hour 4HBA-heparin 
modification leading reduced transport across the membrane.  This could explain why with 
heparin-immobilized microsphere the RR enhancement was 3.5-fold but with a heparin modified 
surface the RR enhancement was approximately 25%.
53
  This could also be the case for CCL2 
but since CCL2 is smaller at 13.1 kDa, CCL2’s diffusion through the modified membrane 
surface is not as hindered compared to VEGF.   
KC/GRO was also analyzed since it is the rat analog of IL-8, a known heparin binding 
protein, and relative recovery increased with the 2 hour 4HBA-heparin modified microdialysis 
membranes.  A similar increase in relative recovery was observed for KC/GRO with the 2 hour 
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4HBA modified microdialysis membranes.   This increase could be due to the electrostatic 
interaction between a negatively charged surface and KC/GRO (pI=9.1) with an overall positive 
charge.  This portion of the dissertation showed successful attachment of heparin onto the 
microdialysis membrane surface.   
Future Prospects 
 In this dissertation the 4HBA modification showed a trend towards increasing RR of 
proteins with a pI greater than the pH of the buffer (pH 7.4), but not for proteins with a pI less 
than the pH of the buffer.  This could indicate an electrostatic attraction between proteins and the 
negatively charged surface.  An interesting future project could be to test if the opposite trend 
could occur with the ethylenediamine modification performed before attachment of heparin.  The 
pKa of the removal of a proton from the first amine is 7.564 and the second is 10.71, so at pH 7.4 
the surface would have an overall positive charge.  This could be tested with the set of analytes 
used in this project to see if altering the charged nature of the PES membrane surface could 
increase RR of analytes with a pI less than 7.4.  This trend could also be further studied for both 
the carboxylic acid and ethylenediamine functionalization using carboxylic acid functionalized 
SPR sensors.  This could be used to investigate the kinetic parameters (kon, koff and KD) between 
the protein and the surface.   
A major area in membrane research is the modification of the membrane surface, and one 
of the purposes of this project was to develop a method to attach molecules containing carboxyl 
or amine functional groups onto the microdialysis membrane surface.  With the attachment of 
4HBA polymers onto the membrane surface, attachment of other amine or carboxyl containing 
molecules can be attached to the membrane surface using EDC/NHS chemistry.  This method 
can be beneficial in a wide variety of ways.  In this dissertation heparin was attached to the 
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surface as a proof of principle experiment to modify the surface as well as to test the effect this 
modification could have on relative recovery of heparin binding proteins.  Another one of the 
future prospects of the project could be to attach different analytes to the membrane surface.  
This could be tailored to a wide variety of applications that use functionalized membrane 
surfaces, such as biomaterials, catalysts in fuel cell systems, and membrane separations.  
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